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1INTRODUCTION
The birth of the first baby, the culmination of the first pregnancy
signifies a momentous occasion in the life of every woman. The aim of
modern management of labour should be to ensure optimum condition for
the mother and the fetus during and after delivery and to render emotional
support and satisfaction. It involves general care and support of the
mother, monitoring the condition of the foetus and progress of labour; so
as to anticipate, recognize problem that endangers the life of both mother
and baby.
Labour pain is due to physiological, psychological, excitatory as
well as inhibitory complex interactions.  Labour pain exceeds the
women’s ante partum expectation. It may affect cardiovascular,
respiratory, urinary, gastro intestinal, neuro endocrine functions due to
supra segmental and segmental reflexes. It also decreases 25% of utero
placental blood flow and causes altered fetal homeostasis.
Painless short labour is usually preferred by every mother and has
been a primary concern of an obstetrician and it has a positive influence
on the course of labour. Thus obstetrical analgesia becomes an essential
2part of modern obstetrics. Various methods of obstetrical analgesia are
available.
Epidural analgesia has been popularly used for pain relief in
western countries for nearly three decades. In India its use is limited due
to lack of trained staff, awareness and monitoring facilities.
Inhalational Entonox contains 50%Nitrous Oxide+50%Oxygen
also used as labour analgesia. It has many advantages like rapid
reversibility, patient controlled system, less possibility of over dosage
and higher oxygen delivery to foetus. It’s disadvantage is the need for
Anesthesiologists. So, it could not be used in smaller hospitals.
Because of convenience of administration, faster absorption as
compared to the oral route IM Tramadol hydrochloride was used for the
study. Tramadol is a weak opioid agent inhibits noradrenergic and
serotonergic neurotransmission and has analgesic activity.
Tramadol allays sympathetic anxiety.  It also inhibits type III
Muscarinic Receptors. M-3 Receptor antagonism causes inhibition of
gastric gland secretion and relaxation of smooth muscle. Thus, it reduces
the duration of labour also.
3In the present study the merits, demerits and outcome of IM
Tramadol hydrochloride as labour analgesic and labour accelerator and
the effect of the drug in both the mother and baby is evaluated.
4REVIEW OF LITERATURE
Labour is the physiologic process by which a foetus is expelled
from the uterus to the outside world. Normal labour is a series of events
which results in expulsion of products of conception at or near term via
naturalis of spontaneous onset for a singleton vertex presentation within
24 hours resulting in a healthy mother and a healthy baby1.
The experience of labour pain has individual variation. Severe pain
is present in nulliparous women than multiparous women. Lowe (2002)
emphasized that the experience of labour pain is a highly individual
reflection of variable stimuli that are uniquely received and interpreted by
each women individually2.
Excessive sympathetic activity will cause incoordinate uterine
contractions, prolonged labour and fetal heart rate abnormalities. Labour
pain may cause subsequent infertility and post traumatic stress disorder.
Risk of postnatal depression is higher in women who have had no pain
relief compared to those with effective analgesia.  Hence, most women
request analgesia to overcome labour pains2.
5According to MELZACK 60 to 80%of women had severe labour
pains, about 23% of primiparous and 11% multiparous women had
horrible labour pain2.
HISTORICAL ASPECTS OF LABOUR ANALGESIA
In 1847, Ether was introduced as first obstetrical anaesthetic agent
by James Young Simpson4. In 1853, Chloroform was used as an
anaesthetic agent by John Snow in Queen Victoria’s 8th child birth. In
1881, Nitrous Oxide was used for labour pains by Stanistav Kilkovitch in
Russia.
In 1902, Hyoscine and morphine were used in labour. In 1908,
Emilfisher and Vommering introduced Barbiturates. In 1912,
Phenobarbitone was used. In 1940 parenteral administration of pethidine
was used. In 1971, Clark used the opioid antagonist naloxone.
Regarding regional techniques Dr.Mueller introduced the first
Pudental block technique (Figure-1). In 1926, Gelut introduced the first
Para-cervical block. The first Lumbar sympathetic block was given by
Dellapiane in 1927. In 1931, continuous Lumbo aortic plexus and caudal
blocks in labour were described by Romanian obstetrician Eugen Begdan
Aburel.  The first Epidural block was given by Graffignino in 1935. In
1946, the first continuous Epidural analgesia was given by Flower et al.
6In 1949, continuous lumbar epidural block in labour was described by
Cleland.
FIGURE -1
In 1945, the syndrome of acid aspiration was described by Curtis
Mendel son, in Caesarean section under general anaesthesia. In 1958,
Ferdinand Lamaze said that labour pain is due to uterine contractions and
it is a conditioned reflex and it could be reduced by psycho prophylaxis.
PHYSIOLOGY OF PAIN
Pain is an unpleasant emotional and sensory experience and it is
due to tissue damage. The pain response is variable among persons.
7Pain is divided into two types,
I. Acute pain
II. Chronic pain
I.  ACUTE PAIN
Acute pain is present over the affected area and it is present for few
minutes. It will produce fight or flight response by means of stimulating
sympathetic nervous system. It will produce increase in respiratory rate,
heart rate, sweating, restlessness, apprehension &dilated pupils. Acute
pain is divided into three types5.
A. Somatic pain
B. Visceral pain
c. Referred pain
IA. Somatic pain
It is again divided into superficial &deep somatic pain.
Superficial somatic pain:
This pain is well localised pricking, throbbing, sharp or burning in
character. It arises from skin, mucous membrane and tissues.
8Deep somatic pain:
It is less well localised, dull aching in nature and arises from tendons,
joints, muscles or bones.
I B Visceral pain
It arises from internal organs or its coverings like pericardium,
peritoneum and parietal pleura.
True visceral pain:
It is diffuse, dull and usually in midline. It has association with abnormal
parasympathetic or sympathetic activity and causes nausea, vomiting,
changes in heart rate, blood pressure and sweating.
Parietal pain –localised:
It is confined to area around organ and it is sharp described as stabbing
sensation.
IC Referred pain
It occurs with visceral pain. It is felt in an area away from the stimulus
site. Because same spinal segment supplies the site of stimulus and the
referred pain area.
9II. CHRONIC PAIN
It is a prolonged pain .It will persist for long time beyond the
normal healing time. It may present for 1 to 6 months. It may be
neuropathic, nociceptive or mixed. It may be intermittent or continuous.
It is poorly understood and it is more complex6.  The  management  is
difficult than acute pain.
In chronic pain, sympathetic nervous system will have adaptation
to persistent pain impulses7. Hence there will not be any fight or flight
reaction. There is evidence indicates that depression and chronic pain
shares the same physiological pathway8. Hence Selective Serotonin
Reuptake Inhibitors and Tri Cyclic Antidepressants have been used for
chronic pain syndromes like neuropathic pain, fibromyalgia and low back
pain9, 10.
THEORIES OF PAIN CONDUCTION
I.  Pain impulse
Based on the nerve fibre types that conduct pain sensation, pain has
been classified as two distinct types.
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A. Fast or First pain:
?? fibres rapidly transmit this pain. A? fibres are thick myelinated
fibres that bring messages rapidly to the brain. This pain is opioid
resistant. Free nerve endings present in the skin mediates this pain.
B. Slow or Second pain:
Unmyelinated, small C fibres transmit this pain. It brings longer
term chronic and throbbing pain. It is relieved by both anti inflammatory
analgesics and Opioids (Figure-2).Deep visceral tissues sense this pain
and it outlasts provoking stimulus. It is secondary to inflammation or
actual tissue damage.
Local anaesthetics block transmission of both types of pain in
nerve fibres.
11
FIGURE-2
II. Pain pathways
Pain stimuli can be regulated at centres in peripheral nervous
system. Pain impulses from A? and C fibres are received in lamina which
is present in dorsal horn of the spinal cord.
Peripheral nerves consist of autonomic, sensory and motor nerve
fibres which are arranged in bundles. Large diameter myelinated nerve
fibres conduct impulses faster than small unmyelinated fibres. The
myelin sheath acts as an insulating layer. Hence it increases the rate of
pain impulse transmission.
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The receptors at the free nerve endings initiate pain impulse.
Painful stimuli are converted into changes in excitability of membranes.
In case of pain the membrane excitability is mediated by prostaglandins,
serotonin, bradykinin, acetylcholine, histamine, potassium ions,
leukotrienes, substance P and free radicals like nitric oxide which are all
released from damaged tissues (Figure-3).
FIGURE-3
From the peripheral receptors painful impulses are conducted by
?? and C fibres in peripheral nerves. First order sensory neuron cell
bodies are located in dorsal nerve root ganglion. It has both centrally
projecting and peripherally projecting axons. Centrally projecting axons
synapses with second order neurons which are all situated in the dorsal
13
horn of the spinal cord. Peripherally projecting axons will become the
peripheral nerves.
Rexed’s 10 Lamina are present in grey matter of spinal cord. The
dorsal horn of the spinal cord is made up of first six lamina(I to VI)
which receives all afferent impulses and act as a site of modulation of
pain by descending and ascending neural pathways.
The marginal layer, the substantia gelatinosa, the nucleus proprius
are the other names for the Rexed Lamina I, II, IV and V.
Second order neurons that are dorsal horn neurons have both wide
dynamic range neurons (WDR) and nociceptive specific neurons.
Noxious stimuli are received by nociceptive specific neurons whereas
non noxious afferent impulses are received by wide dynamic range
neurons. The lamina V of dorsal horn responds to both non noxious and
noxious sensory impulses. It receives both somatic and visceral pain
afferent impulses.
The impulses from the second order neurons are carried by
antero lateral spino thalamic tract which crosses the spinal cord and goes
to opposite side at the level of anterior commissure. This antero lateral
spino thalamic tract goes to the postero ventral nucleus of thalamus, the
14
peri aqueductal grey matter, the nucleus raphe magnus, the reticular
formation and it synapses with third order neurons. Fibres from third
order neuron go to somato sensory areas I and II which are located in post
central gyrus of cerebral hemisphere11.
LABOUR PAIN MECHANISM
In first stage of labour, perception of pain begins with nociceptive
stimuli arises from mechanical and chemo receptors in cervix and
uterus11. Contraction of the uterus generates intense pressure which
stimulates high threshold mechanoreceptors12. In later stages repeated
contraction produces myocellular injury which releases histamine,
serotonin, bradykinin, substance P, potassium ions and acetylcholine
which stimulates chemical nociceptors13.
I. Peripheral pathways
a) First stage of labour or visceral component:
According to Bonica, afferents from cervix and lower uterine
segment accompany the sympathetic nerves (T10-L1) and not the sacral
nerves14.
First stage of labour pain is due to stretching of the cervix and
uterine contractions. It is visceral, diffuse, cramping in nature and poorly
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localized. A? and C afferent fibres carry sensations which pass
sequentially through superior, middle, inferior hypo gastric plexus, the
lower thoracic and lumbar sympathetic chain and ends with T10-L1
spinal nerves (Figure-4). The visceral labour pain sensation is carried by
Unmyelinated C fibres. It is relieved by anti inflammatory analgesics and
opioid.
FIGURE-4
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b) Second stage of labour or somatic component:
Somatic pain predominates during the second stage and late first
stage of labour. It is due to traction and distension of the pelvic
structures, the perineum and the pelvic floor. This somatic pain is carried
through the pudendal nerve to the anterior rami of S2 to S4. It is well
localized, sharp pain unlike first stage visceral pain (which is diffuse,
poorly localized) due to quicker conduction velocity in sacral pathways.
A ? fibre predominantly carries this pain15. Somatic nature second stage
pain is best relieved by local anaesthetics.
In addition to vagina, vulva, perineum sensory innervations S2, S3,
S4 spinal segments also gives motor innervations to various skeletal
muscles of the perineum and pelvic floor. Posterior cutaneous nerve of
thigh supplies lateral and posterior part of perineum. Ileo- inguinal nerve,
genital branch of genito femoral nerve supplies the anterior part of
perineum.
Afferents from the uterus including the lower uterine segment and
the cervix is carried by accompanying sympathetic nerves to the spinal
cord. The nerves, plexus, sympathetic chains that carry afferents are hypo
gastric nerve, the superior and inferior hypo gastric plexus, the lower
17
thoracic and lumbar sympathetic chain. Finally these afferents goes to the
T10 to L1 spinal nerves.
II. Central pathways
After entering into the spinal cord (CNS) the labour pain sensation
travels through both the descending and ascending pathways.
a) Ascending pathways:
 In the dorsal horn of spinal cord (Rexed Lamina I to VI) first
synapse of the ascending pathway occurs. Initially the superficial
substantia gelatinosa (Lamina I and II) are synapse by the most primary
afferent neurons. Deeply located lamina V (WDR), Wide Dynamic
Range neurons are synapse by the locally projecting interneuron. WDR
neurons also receive excitatory input from the large myelinated A?
afferents and Unmyelinated C nociceptive afferents.
All of the Lamina V cells respond to high threshold visceral
afferents and also to cutaneous low threshold afferents from the area of
skin which is supplied by the same spinal segment. This phenomenon is
important for referred pain. It occurs with uterine contraction. Thus cells
of Lamina V provide the neural basis for referred pain phenomenon.
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Dorsal horn grey matter projections cross to the contra lateral
anterior white matter of the spinal cord and then to the limbic and
hypothalamic systems where affective (Emotional) and autonomic
responses originates16.
a) Descending pathways:
It originates from the primary sensory cortex located in post central
area of both cerebral hemispheres. It projects to the midbrain- peri
aqueduct grey matter which further projects to the thalamus- postero
ventral nucleus.
From the postero ventral nucleus of the thalamus, through the dorsi
lateral funiculus projections enter the spinal cord and ends in the grey
matter (Dorsal horn) of spinal cord17.
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LABOUR PAIN CAUSES
Labour pain is caused by variety of noxious stimuli. It gives both
objective alterations in autonomic nervous system and cardio-respiratory
function and subjective discomfort.
? Hypoxia during Myometrial contraction
? Myometrial contraction produces hypoxia leads onto lower
abdominal pain. The pain severity is increased if there is no uterine
relaxation between contractions to allow adequate oxygenation.
Uterine contractions and sympathetic hyperactivity causes
vasoconstriction leads onto ischemia of the myometrium.
FIGURE - 5
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Relationship between duration of lower abdominal pain due to
increased intensity of uterine contractions and duration of uterine
contractions is drawn in each stages of labour. In early first stage, to
evoke pain the intensity of contraction should reach 25mm/hg18. There is
a time lag of 20 seconds for pain perception (Fig-5). In late first stage of
labour, the time lag for pain perception is shortened from 20 seconds to
10 seconds. The intensity of pain, the intensity of contraction and the
duration of the contraction is increased. In second stage of labour, the
time lag for pain is shortened to 5 seconds, the intensity and duration of
contraction reaches a peak14. . Though the intensity of postpartum uterine
contractions are less the magnitude is 2-3 times great19.
? Uterine contraction also causes pressure on the afferent nerve
endings which are located between the Myometrial fibres also
causes lower abdominal pain.
? Cervix stretching produces pain in the low back area.
? Pressure on the Para cervical ganglia and ganglia surrounding the
vagina produces pain.
? Traction on the ovaries, tubes and the peritoneum produces pain.
? Stretching and traction on the supporting ligaments.
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? Pressure on the bladder, urethra and rectum.
? Distension of the perineum and the muscles of the pelvic floor also
cause pain during the labour20.
LABOUR PAIN EFFECTS
Labour pain has deleterious effect both on the foetus and mother21.
The effect of labour pain are mediated at three levels
a) Cortical
b) Supra segmental
c) Segmental
I. Cortical level:
Cortical level impulses arise from somato sensory cortex and
mediated through neo spino thalamic tract. It causes fear, anxiety,
arousal, emotional, behavioural changes and motor activity changes.
I. Supra segmental level:
Connection of reticular formation with paleo spino thalamic tract
mediates this impulse. It causes hyperventilation and increase in ACTH,
23
FIGURE-6
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Aldosterone, Cortisol levels and also increases oxygen consumption
(Figure-6). At or after delivery it reaches a peak22.
Ventilation is increased from 10 litres per min (normal mean)
between contractions to 23-35 litres per min during contractions. Tidal
volume and minute volume is also increased.
II. Segmental level:
This effect is caused by local neuronal connection at the spinal
cord. It causes delayed gastric emptying, decreased gastric motility,
nausea, vomiting and ileus.
LABOUR PAIN CLINICAL CHARACTERISTICS
First stage labour pain (i.e., uterine contraction pain) clinical
character is different from the second stage labour pain (i.e., delivery
pain) suggested the presence of distinct neural pathways (Figure-7).
A. Early first stage- Latent phase:
Uterine contraction will produce aching, cramping, diffuse,
visceral pain referred to low back area T11, T12 dermatome which
receives afferents from both viscera and cutaneous dermatome.
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B. Late first stage-Active phase:
Intensity of uterine contractions increases, severe pain occurs over
T10-L1 spinal dermatome it is associated with dilation of cervix.
C. Early second stage:
Uterine contractions intensity increases and severe pain present in
T10-L1 dermatomes. Descent of the presenting part of the foetus occur
which causes pressure over the pelvic structures and moderate pain over
low back area and perineum and mild pain over thighs and legs.
D. Late second stage-Delivery pain:
Descent of the presenting part of the foetus produces well localized
severe, sharp, somatic pain over the lower part of sacrum, vagina, rectum
and perineum which is supplied by pudendal nerve (S2, S3 and S4).
Uterine contraction will produce moderate pain over T10-L1 segments.
Severe pain present over L2-S1( lower lumbar, sacral dermatome)
due to pressure on lumbo sacral plexus and nerve roots, stretching of
fascia, muscles, ligaments and due to traction on uterine ligaments, pelvic
parietal peritoneum and due to pressure on the urethra, bladder and
rectum23.
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INTENSITY AND DISTRIBUTION OF LABOUR PAIN
DURING EACH STAGES OF LABOUR
FIGURE-7
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PAIN MEASUREMENT METHODS
Pain score is recorded by patient’s history. The pain score should
be reliable, valid and geared to the patient. Dolorimeter is the instrument
used to measure pain 24.
PAIN ASSESSMENT
Numeric Pain Intensity Scale
The Numeric pain intensity scale is used to measure pain score.
0-1    : NO PAIN
2-4     : MILD PAIN
5-7     : MODERATE PAIN
8-10   : SEVERE PAIN
After administration of drug during labour, if the patients have
good pain relief means their pain score will be between 0-1(no pain). If
28
they have moderate pain relief means their pain score will be between2-4
(mild pain). If they have mild and no pain relief means their score will be
between 5-7 and 8-10 respectively.
Pain Rating Scale
Intensity of pain is expressed by different facial expression.
This pain rating scale is used in paediatric age group.
Degrees of pain by Visual Analogue Scale
According to VAS 4 Grades of pain present-10 cm scale is used25.
Grade-1    -No pain
Grade-II    -Slight pain but comfortable
Grade-III  -Moderate pain with discomfort
Grade-IV  -Severe pain /maximum pain
.
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Mc Gill pain questionnaire- Pain rating index
In this questionnaire pain scores are given to various types of pain.
30
METHODS OF LABOUR ANALGESIA
Various methods of pain relief are present .Selection of pain
relief method depends upon the availability of technique and the choice
of the individual.
An ideal analgesic technique should fulfil the following criteria:-
? It should be cheap and easy to administer.
? It should produce good, reliable pain relief.
? It should not impair consciousness and cooperation.
? It should not be toxic to mother and foetus.
? It should not produce cardio respiratory depression in foetus26.
? It should not have any tocolytic action and it should not delay
labour.
? It should allow the patient to ambulate during early stages of
labour
?  It should not have any long term effects on the mother
31
Non
Pharmacological Pharmacological
Systemic Regional
Trans cutaneous
electrical nerve
stimulation  (TENS)
Inhalational methods Lumbar epidural
analgesia
Relaxation/breathing
techniques
Systemic analgesics CSEA
Bio feedback and
physical therapies
Opioid analgesics
(Meperidine, Morphine
Fentanyl, Sufentanil,
Alfentanil,Remifentanil)
CSA
Temperature
modulation: hot or
cold packs, water
immersion
Non opioid analgesics
Agonist-antagonist
analgesics(Nalbuphine,
Butarphanol, Tramadol)
Alternative
regional anesthetic
techniques
Lumbar sympathetic
block27, Pudendal
block,    Para
cervical block
Hypnosis Tranquillizers
(Barbiturates,
Phenothiazine
derivatives,
Benzodiazepines)
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Massage Dissociative or amnesic
drugs (Ketamine,
Scopolamine)
Acupuncture
Aromatherapy
OPIOID ANALGESIA
It comes under systemic analgesia method. It will not require
specialized equipment or personnel. It can be given by intramuscular,
subcutaneous or intravenous route. Intravenous route is either intermittent
or continuous IV infusion. Regarding the rate of onset of analgesia IV
route has quicker onset, IM route has delayed onset.
CLASSIFICATION OF OPIOID ANALGESICS
Natural opium alkaloids Morphine and codeine
Semi-synthetic Opioids Diacetyl Morphine (Heroin), Pholcodeine
Synthetic Opioids
Pethidine (Meperidine), fentanyl,
methadone, dextropropoxyphene,
tramadol, ethoheptazine28.
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OPIOID RECEPTORS
Opioid receptors are present on neurons in the peripheral tissues
and in the central nervous system. Three types of opioid receptors µ, ?,
and ? are present in brain, spinal cord and peripheral tissues. Sub-types
are present for ? and ? receptors.
ACTIONS ASCRIBED TO DIFFERENTIATE TYPES OF OPIOID
RECEPTOR
?(mu) ?(kappa) ?(delta)
Analgesia (supra
spinal
? 1 + spinal ? 2 )
Analgesia (spinal ?1 )
(supra spinal ? 3 )
Analgesia (spinal +
affective component of
supra spinal)
Respiratory depression
?? 2 )
Respiratory
depression  (lower
ceiling)
Respiratory depression
Euphoria Miosis (lower ceiling) Affective behaviour
Miosis Dysphoria Reinforcing actions
Reduced GI motility  Hallucinations Reduced GI motility
Physical dependence
(morphine type)
Physical dependence
(Nalorphine type)
Sedation Sedation
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NORMAL LABOUR
Labour is a multi factorial process, which involves uterine activity,
cervical ripening and dilatation of cervix with expulsion of the foetus and
placenta in an orderly manner. As well stated by Myerscough29 if we
were restricted to using only a single index in the progress of labour, then
unhesitatingly we would drive the most reliable evidence of satisfactory
advance in Primigravida at least from observations of increasing cervical
dilatation.
 Friedman30 (1978) in his study on labour stated that ‘’the clinical
features of uterine contraction namely frequency, intensity and duration
cannot be relied as measure of normality... except for cervical dilatation
and fetal descent , none of the clinical features of the parturient appear to
be useful in assessing labour progression.
STAGES OF LABOUR:
Although labour is a continuous process it has been classically
divided into three well-known stages.
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FIRST STAGE:
The first stage of labour begins with good uterine contractions of
sufficient frequency, intensity and duration and ends when the cervix is
sufficiently dilated to allow the passage of fetal head. It was Friedman31
(1978) who begun a scientific approach to study the progress of labour.
He plotted the rate of cervical dilation against time graphically and
developed the concept of three functional divisions and the pelvic
division.
During the preparatory division, only minimal cervical dilation
takes place. It is during the dilatational division maximum cervical
dilation takes place. It is understood better by dividing it into two phases,
the latent phase and the active phase32. The latent phase corresponds to
the preparatory division and the active phase to the dilatational division.
Latent phase is again divided into Early latent and Late latent phase.
PHASE 0:
Beginning even before implantation a remarkably effective period
of Myometrial quiescence is imposed. This phase is characterized by
uterine smooth muscle tranquillity with maintenance of cervical structural
integrity. To prepare the uterus for labour, the Myometrial tranquillity
36
must be suspended through what has been called as uterine awakening or
activation.
DILATATION CURVE IN NULLIPAROUS WOMEN
Studies of Liggins and Thorburn33 revealed that fetal neuro
endocrine signals originating in the hypothalamus initiate a cascade of
events that activate the fetal hypothalamic- pituitary-adrenal axis to
increase fetal glucocorticoid production which in turn increased
oestrogen and activated the contraction associated protein causing uterine
contractility.
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LATENT PHASE:
Latent phase is divided into Early latent and Late latent phase.
During Early latent phase uterine contraction along with cervical
effacement takes place. Late latent phase ends with 3-4 cm of dilatation.
ACTIVE PHASE:
This phase starts with cervical dilatation of 4 cm and ends with full
dilatation. Friedman31 subdivided the active phase into the acceleration
phase, the phase of maximum slope and the deceleration phase.
The acceleration phase begins with 2.5 cm of cervical dilatation
and lasts up to 4 cm. The phase of maximum slope is from 4 to 9 cm. The
phase of deceleration is from 9-10 cm. According to Friedman31 the mean
duration of active phase of labour in nulliparous women was 4.9 hrs with
the standard deviation of 3.4 hrs. The active phase was reported to have
statistical maximum of 11.7 hrs with considerable variation in duration.
PELVIC DIVISION:
The pelvic division commences with deceleration phase of cervical
dilatation. The classical mechanism of labour that involve cardinal fetal
movement in a cephalic presentation –engagement, flexion, descent,
38
internal rotation, extension, restitution and external rotation all takes
place principally during the pelvic division.
FUNCTIONAL DIVISIONS OF LABOUR
SECOND STAGE OF LABOUR:
Begins with complete dilatation of the cervix to the delivery of the
foetus.
THIRD STAGE OF LABOUR:
Extends from the time of delivery of foetus up to the delivery of
placenta and its membranes.
39
CERVIX IN LABOUR
The uterine cervix has generally been considered as an inert organ,
playing a passive role in labour. During most of pregnancy the cervix
must remain unyielding and reasonably rigid. With the initiation of
parturition the cervix must often soften, yield and become more readily
dilatable.
The cervix is a tubular connective tissue structure composed of
three principal components, viz. Collagen, smooth muscle and the
connective tissue or the ground substance. According to Rorie and
Newton 34(1967) the muscle components as determined by planometry
is29% in the upper third,18% in the middle third and 6% in the lower
third and 69% in the corpus of uterus.
Schwalm and dubrausky35 (1966) reported that the cervical muscle
content to be between 2% to 5%.  However, the arrangement of the
muscle fibres facilitated effacement and dilatation. The muscle fibres
near the internal os lies in continuum with the outer longitudinal fibres of
the myometrium, while the muscle fibres near the external os are
circularly arranged.
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The extra cellular matrix contains fibrillar components like
collagen, elastin, proteoglycans, glycoprotein and other proteins. The
chemical compositions of the identified constituents are relatively well
established showing the predominance of collagen.
Collagen types I and III are the main types found in the human
cervix. Kleissl et al36 (1978) found 62 – 80% of collagen type is I and 20
– 30 % is type III. Tropocollagen, the characteristic subunit of the
interstitial collagen consists of three polypeptide chains joined together in
triple helix. The amino acid composition of this helix is unique. Glycine
the smallest amino acid in every third position allows tight packing of the
triple helix.
COMPLICATIONS OF PROLONGED LABOUR
Labour is said to be normal in retrospect and said to be prolonged
when the combined duration of first and second stage is more than the
arbitrary time limit of 18 hours. The aim of monitoring the progress of
labour is to prevent prolonged labour. A labour which is unduly
prolonged can lead to maternal or fetal distress37. Uterine contractions,
cervical resistance and the forward pressure exerted by the leading fetal
head are the factors influencing the progress of the first stage of the
labour.
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Infection may complicate prolonged labour and pose a serious
danger to mother and foetus. After the rupture of membrane bacteria
enter the amniotic fluid, traverse the amnion and invade deciduas and
chorionic vessels, that causing maternal and fetal bacteraemia ending in
sepsis. Fetal pneumonia caused by aspiration of infected amniotic fluid, is
another serious   consequence. Rarely, localized rings or constrictions of
the uterus develop in association with prolonged labour.
During childbirth the pelvic floor is exposed to direct compression
from the fetal head as well as to downward pressure from maternal
expulsive efforts. These forces stretch and distend the pelvic floor,
resulting in functional and anatomical alterations in the muscles, nerves
and connective tissue.
According to Leitch and Walker 38(1998) Sultan and Stanton39
(1996) the effects on the pelvic floor during childbirth lead to urinary and
anal incontinence and to pelvic organ prolapse. Currently there is
uncertainty regarding the incidence of childbirth associated pelvic floor
injury, Samuelson and associates40 (1999).
Sokol and co-workers41 (1977) reported that 25% of nulliparous
labours were complicated by active-phase abnormalities. Friedman42
(1972) subdivided active – phase problems into protractions and arrest
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disorders. He defined protraction as a slow rate of cervical dilatation or
descent, which for nulliparous was less than 1.2 cm dilatation/hour or less
than 1cm descent / hour.
Arrest is defined as a complete cessation of dilatation or descent.
Arrest of dilatation was defined as 2hours with no cervical change and
arrest of descent as 1 hour without fetal descent.
ACTIVE LABOUR PHASE ABNORMALITIES
Abnormal labour patterns
Diagnostic criteria in
nulliparous women
1. Prolongation disorder (prolonged
latent phase)
>20hrs
2. Protraction disorders
         Protracted active –phase dilatation
         Protracted descent
<1.2 cm/hr
<1.0cm/hr
3. Arrest disorders
a. Prolonged deceleration phase >3hr
b. Secondary arrest of dilatation >2hr
c. Arrest of descent >1hr
d. Failure of descent No descent in deceleration
phase or second stage
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Effectively the overall duration of labour is determined by the
length of the first stage, because the number of hours taken for the cervix
to dilate represents 90% of the entire birth process (Olah ks et al 1992)43.
Though 90% of duration of labour is contributed by first stage of labour,
no acceptable medical and surgical methods are available to reduce the
duration of first stage.
Active management of labour was introduced into clinical practice
in 1963 at national hospital, Dublin or Driscoll 44and colleagues
disciplined and standardized the labour management protocol.
Desai et al., (1982)45 in their study of valethamate bromide
accelerated the first stage of labour provided patients were in late latent
labour. They also reported that valethamate use was unsatisfactory in
thick uneffaced cervix and also on patient with ineffective uterine
contraction. Baser et al (1993)46 profoundly supported desai study.
Singh et al., 47 studied the effect of drotaverine in acceleration of
labour and found that there was increased incidence of atonic post partum
haemorrhage and it offered no pain relief.
Episiotomy and assisted vaginal delivery are widely used methods
in second stage of labour to facilitate delivery. Advantage of prophylactic
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episiotomy included reduction in the duration of the second stage and
reduction of trauma to the pelvic floor musculature, (Goodlin et all) 48.
Thilanganathan et al.,49 (1993) compared a regime of active
management of the third stage with syntometrine and controlled cord
traction and concluded that though the length of the third stage of labour
was reduced, there was no significant reduction in blood loss compared to
the physiological management . Mitchelle and Elbourne50 (1993) found
that syntometrine was more effective in prevention of postpartum
haemorrhage.
Philpott (1972) 51,  O’  Driscoll  et  al  (1973)52, Studd (1973)53,
Illancheran et al, (1977)54 studied the effect of the rate of cervical
dilatation in various ethnic groups in different countries. The
normograms derived show similar rates of dilatation in various ethnic
groups and studies have confirmed that ethnicity has little influence on
the rate of dilatation.
Hellman and Prystomsky et al, (1952)55, had conclusively proved
that, in primi, the perinatal loss mounted rapidly when the first stage of
labour exceeded 20 hours. Acceleration of labour to shorten its duration
without jeopardising the maternal and fetal condition would therefore,
minimise the maternal and fetal morbidity and mortality.
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Kieran O Driscoll et al (1973)56 adopted a policy of active
management to ensure that every patient delivered within 12 hours.
Cervical dilatation was plotted on a simple graph (Friedman, 1967)26. He
stated that intervention was mandatory unless cervical dilatation
exceeded one centimetre each hour.
Pajntar  M  et  al57 studied the contribution of cervical smooth
muscle activity to the duration of latent and active phases of labour and
concluded that, cervical smooth muscle activity contributed to the
duration of the latent phase.
L .D. Cardazo et al58 in their study of predictive value of
cervimetric labour patterns in Primigravida concluded that a prolonged
latent phase was associated with caesarean section rate of 16 .77.  They
also reported that the rate of cervical dilatation played a vital role in the
comparison of incidence of vaginal delivery and caesarean section rate.
Application of antispasmodics in obstetrics was first introduced by
Von kries59 and his pupils in 1923. A remarkable shortening of the
duration of labour was obtained by using spasmalgin.
In 1943, Mauks60 reported a definitive shortening in the duration of
labour by the use intramuscular troparin (a papaverine and methyl
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atropine bromide) an antispasmodic drug in primiparous as well as
multiparous women.
In 1948, Sauter61 studies used di hydro ergotamine as a cervical
relaxant in cases of delayed labour, but later its action was proved to be
due to its oxytocic properties by Embery and Gareh.
Gupta et al62 studied the effect of intra cervical injections of
hyaluronidase in Primigravida women during labour. It caused
acceleration and shortening of the first stage of labour. They concluded
that it significantly shortened the active phase of labour by 2.09 hours.
Charankachu63, Herabutya64 et al in their study on cervical ripening
and dilatation by Glycerol trinitrate and isosorbide trinitrate reported that
both the drugs were not of much use and also were associated with severe
maternal side effects like headache and hypotension.
Wm .J. Stevens65 (1932) first reported the use of hyoscine in labour
which included 200 women concluded that duration of labour was
shortened. No drug intolerance and contraindications were encountered.
Roland et al66 (1956) in their study noted the effects of barbiturates
in obstetrics, among the various types of drug combination used to
47
produce analgesia, Hyosine with Demerol was least detrimental to the
foetus.
Melzack and wall‘s (1965)67 introduced the “Gate control theory”
and explained the various methods of pain relief in labour.
The American college of obstetricians and gynaecologist (2004) 68
have specified that it is the responsibility of the obstetrician to develop
the most suitable response to accomplish the request for pain relief.
Hence taking into the consideration of advantages and disadvantages of
various methods of pain relief and labour acceleration, IM Tramadol
hydrochloride is found to be effective in pain relief and also shortening
the duration of labour
TRAMADOL
In 1971, Tramadol HCL, a narcotic drug was introduced in
Germany. This newly introduced analgesic acts centrally and relieves
pain by opioid agonism. It has weak affinity over ? and ? opioid receptors
and moderate affinity over µ opioid receptor. It inhibits 5 hydroxy
tryptamine and noradrenalin reuptakes and it activates monoaminergic
spinal inhibition of pain. Dose is 1 – 2 mg / kg body weight. It has 10%
of morphine’s potency. Its side effects lower than morphine.
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Onset of action is within 15 minutes and lasts for 2 – 3 hours. Its
tolerance is good and it is safe in heart disease patients and its abuse
potential is very low. Placental permeability of the drug is high.
However, neonate’s hepatic enzymes will metabolize Tramadol. The side
effects of Tramadol can be partially reversed by the opioid antagonist
Naloxone.
Chemical structure
It is a racemic mixture of 2 enantiomers (+) tramadol and (–)
tramadol and has chemical structure: (IR, 2R)–ve/–2–{(dimethyl amino)
methyl]-1-(3-methoxyphenyl) cyclohexaonl hydrochloride.
Molecular formula: C 16 H 25 NO 2 HCl
It has dual mechanism of action. It is a synthetic codeine analogue
( 4 phenyl piperidine analogue).
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Characteristics:
? odourless
? White to off white crystalline
? Soluble in water and ethanol
?  Molecular weight-299.84
?  Characteristic unpleasant taste which is mildly bitter
? pKa value is 9.3 at 293 K
? pH 6-6.8
? Available as drops, capsules, injections and suppositories. It
is an aqueous sodium acetate buffered solution.
Mechanism of Analgesia
By two pathways it produces analgesia.
1. Opioid pathway:
It acts as an agonist on µ, ? and ? receptors. The duration of action
is comparable to morphine. This opioid analgesic action is reversed by
naloxone.
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2. Non-opioid pathway:
It increases the pain threshold by means of inhibiting the reuptake
of serotonin and noradrenalin and by activating the mono aminergic
spinal inhibition of pain. It also acts as an antagonist over M1and  M3
Muscarinic, nicotinic receptors, 5HT2C receptor, NMDA and GABA-A
receptor.
Pharmaco-kinetic properties:
Absorption:
Bio availability is 100% for IM route.
Bio availability is 68-100% for oral route.
Distribution:
It is 20% plasma protein bound. It crosses the placenta (80%).
Metabolism:
It is metabolised by demethylation via cytochrome P450
isoenzyme in liver.
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Excretion:
90% of the drug is excreted through the kidney. 10% of the drug is
excreted through faeces. T ½ is 5 hours. Elimination half life is 5-6 hours.
T ½ is increased in patients with kidney and liver problem. It is
contraindicated in end stage renal disease patients.
Therapeutic efficiency:
IM Tramadol 50-150 mg is equal to 50-100 mg of IM pethidine.
Tramadol 100mg is equal to 10mg of morphine.
Dose:
50-150mg (or) 1-2mg/kg/body weight/ 4-6 hourly.
Maximum dose is 400mg/day.
Administration:
Oral, Intra-venous, Intra-muscular, Per-rectal.
Actions:
CNS:
Analgesic efficacy is equal to pethidine.
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CVS:
It reduces pulmonary artery pressure; hence it can be used for pain
relief in heart disease patients. Eg: Acute Myocardial Infarction,
Diagnostic cardiac catheterisation.
RS:
Therapeutic dose does not have any effect on tidal volume,
respiratory rate. Effective analgesia decreases pain induced
hyperventilation. Over dosage may cause respiratory depression.
Other effects:
It has minimal smooth muscle relaxation action; hence it may
cause urinary retention, constipation and cholestasis. It has anti-tussive
and dose dependent mydriasis effect. On long term use, it will not
produce addiction, tolerance and dependence.
Indication:
It is used for the treatment of moderate to acute severe pain and
chronic pain due to surgical procedures, cancer, MI, trauma, painful
diagnostic procedures and obstetric pain.
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Interaction with other drugs:
It has interaction with MAO inhibitors. Eg: anti-depressants.
Contraindication:
It is contraindicated in acute intoxication with hypnotics, alcohol,
CNS acting drugs and analgesics.
IV Tramadol is contraindicated in patients with epilepsy.
Side effects:
Nausea, dry mouth, vomiting, hot flushes, transient tachycardia,
fatigue, dizziness, sweating.
Over dose and intoxication:
Symptoms are salivation, restlessness, cyanosis, Mydriasis, ataxia,
prostration, cramps, dyspnoea, tremor, vomiting.
Opioid Antagonists:
Naloxone is the opioid antagonist is used to reverse the neonatal
respiratory depression caused by opioid use during labour. Dose: is 10
microgram/Kg. It is given in the cord. It can be given through IM, IV and
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SC routes. It reverses the depression of minute ventilation in new born.
The dose is 0.1mg/Kg of a 1mg/ml solution.
REVIEW OF TRIALS WITH TRAMADOL ON LABOUR
ANALGESIA  AND LABOUR ACCELERATION
A study conducted in Iran in 2009, in 160 full term pregnant
women by Maryam khooshideh and Ali shahriari compared the effect of
IM pethidine 50mg and IM Tramadol 100mg in labour. Regarding pain
relief IM pethidine gives good analgesic effect in second stage of labour
but IM Tramadol exhibits moderate pain relief in first stage of labour69.
Labour duration shortened in Tramadol. Incidence of maternal and
neonatal side effects is lower in Tramadol group.
A non randomised trial conducted in 2010 by RAO ZA et al, in
which they studied the labour duration and delivery mode after giving
walking epidural with 0.5% Tramadol and 0.1% Bupivacaine. This study
results showed reduction in labour duration.
A study conducted in 2000 by Fieni S Angeri F et al, in which they
compared parenteral Meperidine and Tramadol for effective pain relief in
Labour. The study results showed that tramadol gives good pain relief
with good tolerability without any neonatal and maternal complications70.
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Parenteral tramadol compared with pethidine in 1980 by Bitsch M
et al. Though both groups had similar pain relief they recommended
Tramadol because it did not produce any maternal and neonatal
respiratory depression71.
Hussain P et al studied the effect of pain relief in labour between
100mg pethidine and 100mg tramadol in 1987. Analgesic effect of
pethidine and Tramadol was similar but the side effects are less in
Tramadol groups72.
IM Tramadol is used for pain relief in MI, Trauma and labour. This
study was conducted by Lehman KA in 1994. This study showed that IM
Tramadol has good analgesic effect in Labour pains73.
A study on management of labour pains with tramadol, conducted
by Rad brach L et al, in 1996 showed that tramadol produces good
analgesic effect without neonatal respiratory depression74.
A study on pain relief in normal labour and abnormal labour was
conducted by Sarkar B, Mukhopadhyay AK in 1997, between IM
pethidine and IM Tramadol. The incidence of fetal respiratory distress,
caesarean section and labour duration were low in Tramadol group75.
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A study conducted by claahsen-Vander Grinten HL et all in 2005
to study the effect of Tramadol in newborn whose mothers  in 1st  stage of
labour were given IM Tramadol as pain relief. Maternal and neonatal
blood samples were taken at immediate post partum, and 1, 2, 3, 6and
12hrs after postpartum76.
Foetal blood samples showed the presence of Tramadol and its
metabolites equivalent to maternal blood levels.  Though it indicates high
placental permeability of Tramadol, it has no effect on neonatal APGAR.
It produces pain relief in labour with maternal side effects like nausea,
drowsiness without changes in cardio respiratory system and respiratory
system. This study concluded that the effective dose of the drug is
1mg/kg body weight.
A comparison study of IM Tramadol in labour and no drug in
labour was done by Usha rani Sharma, Verma RS in 1997.  The results of
the study showed that the drug Tramadol produce excellent analgesia
without any side effect in mother and newborn and confirmed its safety
of usage in labour77.
Analgesic effect of Morphine, Pethidine and Tramadol was
compared by Parasert sawat et al in 1986. All the 3 drugs produced
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almost similar analgesic effect.  The difference in analgesic effect among
the 3 drugs is statstistically not significant78.
Nagesh kumar did a study in a health centre in 2004.  He selected
100 labouring women and has given IM Tramadol to 50 patients and IM
distilled water to 50 patients.  He compared both groups and concluded
that Tramadol is a safe analgesic and it also reduces the duration of
labour and it can be given in any primary health centre with minimal
monitoring facilities without any maternal or neonatal side effects79.
A comparative study between Tramadol and Pentazocine by Singh
S in 2001 as labour analgesics concluded that analgesic effect was 80%
with Tramadol and 60% with Pentazocine with slightly more maternal
and neonatal complication in Pentazocine groups80.
16 trials of IM Opioids as labour analgesics were studied by
Elbourne D and Wiseman RA and they concluded that the degree of pain
relief, drug delivery interval and mode of delivery showed no difference
between Pethidine and Tramadol group81.
The programmed labour produces good pain relief, shortens the
duration of labour and reduces the blood loss in third stage.  These effects
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were evaluated by Meena Jyothi, Singhal prabha, Choudary Devika in
2006. It has no fetal side effects82.
              A comparison study of IM Pentazocine and IM Tramadol as
labour analgesics was conducted by Nagaria tripti, Acharya Jyotsna in
200683 in 200 term labouring women. In Tramadol group about 37% of
patients had satisfactory pain relief, 38% of patients had moderate pain
relief and 16% had mild pain relief.
In Pentazocine group 14% of patients had satisfactory pain relief,
34% had moderate pain relief and 42% had mild pain relief.  The labour
duration, side effects of the drug and drug delivery interval were less in
tramadol group.
The safety and efficacy of IM Tramadol 100mg in 100
Primigravida was studied by Sudha patil et al84 in 2012.  58% of patients
had good pain relief, 30% of patients had moderate pain relief, and 12%
of patients had mild pain relief.
Safety and analgesic efficacy of IM Tramadol 50mg, IM Tramadol
100mg and IM pethidine 75 mg in 90 labouring Primigravida patients
were studied and compared by Viegas OA et al85 in  1993.   Similar
percentage of pain relief was present in both 75mg pethidine and 100 mg
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of Tramadol group.  Respiratory depression and adverse effects of the
drug were common in Pethidine group.  Tramadol has fewer side effects
than Pethidine.
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AIMS OF THE STUDY
To study the effect of IM Tramadol hydrochloride in labour.
1. To study the effectiveness of pain relief by opioid agonism.
2. To evaluate the reduction in duration of first stage of labour
if any (by inhibiting sympathetic activity and M3 receptor
antagonism)
3. To ascertain any side effect on mother and foetus.
4. To evaluate the cost effectiveness of the drug.
61
MATERIALS AND METHODS
MATERIALS
Drug
IM Tramadol hydrochloride
1 ampoule contains 2 ml
Route: IM
1 ml is equal to 50 mg
Dose: 100mg (1mg per kg body weight)
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METHODOLOGY
STUDY DESIGN: Comparative prospective interventional study.
CASE SELECTION
A total of 400 Primigravida who were admitted to the labour ward
of GOVT RSRM LYING IN HOSPITAL during the period October 2012
to November 2013, in late latent phase (i.e.,) with cervical dilation of  2-
3cm  were enrolled in this study. They had fulfilled the inclusion criteria
and exclusion criteria with informed consent.
CRITERIA FOR SELECTION OF CASES
Inclusion criteria
1.  Primigravida
2. 18-35years of age
3.  Thirty seven completed weeks of gestation
4.  2-3cm of cervical dilatation
5.  Adequate pelvis for vaginal delivery
6 . Intact membranes
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7.  Singleton foetus
8.  Vertex presentation
9.  Went in for spontaneous labour.
10.  Informed and written consent
Exclusion criteria
1.  Multigravida
2.  Patients allergic to Tramadol hydrochloride after subcutaneous test
dose
3.  Pregnancy with medical, surgical or obstetric complication such as
ante partum hemorrhage, preeclampsia, malpresentations and
cephalopelvic disproportion.
4.  Induced labour
5.  Cervical dilatation greater than 3cms.
6.  Ruptured membranes.
7.  Patients who have not given consent for the study
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The first 200 patients fulfilling the inclusion criteria in late latent
phase of labour consenting to the study were recruited to take part
in the study.
The selected patients were randomly divided into two groups
I and II.
Group I and II
? Group I was given IM Tramadol hydrochloride 100mg in late
latent phase of labour.
? Progress of labour was monitored by Partograph.
Effectiveness of the drug was assessed by noting
? Pain score before and after drug administration.
? Numeric Pain Intensity Scale is used for assessing labour pain
severity
? The duration of the first stage
? Total duration of labour
? Mode of delivery
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? Maternal side effects
? Fetal outcome
? Duration of hospital stay
? Group II was a control group, without giving Tramadol, the above
mentioned were observed.
? General physical examination and obstetric examination were done
in all cases.
? Neonatal management is as per routine protocol.
The following were noted:
? Pain score of the patient before and after drug administration.
? Onset of drug action.
? Progress of labour was monitored by partograph.
? Duration of labour.
? Fetal well being is confirmed by cardiotocography
? Mode of delivery and reason for the same were analyzed.
? Maternal side effects, Complication during labour were analyzed
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? Weight of the baby and APGAR score were recorded
? Cost effectiveness, the dosage of the drug and the number of doses
required to reduce the duration of labour were analyzed.
? Efficacy in pain relief was assessed by using Numeric Pain
Intensity Scale. Observations were made at 0, 30, 60, 90 and 120
minutes after the medication.
INDICATION FOR ENHANCEMENT OF DOSAGE
 Initial dose of drug was given at 2- 3cm dilatation of cervix. The
patients were reviewed after 2 hours and dose repeated for the patient
who had severe pain and withheld in patients who had already entered
into the second stage.
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OBSERVATIONS AND RESULTS
    TABLE –I
AGE DISTRIBUTION BY GROUP
AGE IN YEARS
Group I
n=200
Group II
n=200
No % No %
18-20 43 21.5 55 27.5
21-25 106 53.0 101 50.5
26-30 41 20.5 34 17.0
30-35 8 4.0 8 4.0
>35 2 1.0 2 1.0
Pearson Chi-Square= 2.243, df =4          p value
Table I shows age distribution of Primigravida by group. Majority
of the Primigravida found to be between 21-25 years of age in two
groups. The chi square statistical test infers that age distribution was
similar in the two groups. The range difference between the age groups of
I and II were not statistically significant. Hence the two groups were
comparable age wise.
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TABLE II
GESTATIONAL AGE BY GROUP
GESTATIONAL AGE IN
WEEKS
Group I Group II
No % No %
37-38 18 9.0 35 17.5
38.1-39 73 36.5 70 35.0
39.1-40 90 45.0 75 37.5
>40 19 9.5 20 10.0
Pearson Chi-Square = 6.905,        df = 3,          p value= 0.075
               Table II shows the period of gestation of Primigravida by group.
Majority of the patients were found to be between 39.1-40 weeks
gestational age. The chi square statistical test shows that the gestational
age distribution was similar in the two groups. No statistical difference in
the gestational age was established in the two groups.
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TABLE III
PAIN IN STAGE I
DEGREES OF
PAIN
Group I Group II
No % No %
NO PAIN (0-1) 0 0 0 0
MILD(2-4) 0 0 0 0
MODERATE(5-7) 26 13.0 29 14.5
SEVERE(8-10) 174 87.0 171 85.5
Pearson Chi-Square =0.141,            df =1,          p value=0.707
           Table III shows degree of pain in stage I before drug
administration in both groups. In stage I, 87% of the patients in group I
and 85.5% of the patients in group II had severe pain and 13% of patients
in group I and 14.5% of the patients in group II had moderate pain. The
pain score before drug administration is comparable in both groups (p
value-0.707). No statistical difference in pain score in stage I was
established in the two groups.
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TABLE IV
PAIN IN STAGE I BEFORE AND AFTER DRUG
ADMININTRATION IN STUDY GROUP
DEGREES OF
PAIN
STAGE I BEFORE
DRUG
STAGE I AFTER
DRUG
No % No %
NO PAIN (0-1) 0 0 0 0
MILD PAIN(2-4) 0 0 47 23.5
MODERATE(5-7) 26 13.0 77 38.5
SEVERE(8-10) 174 87.0 76 38.0
Stage I before mean=3.8680   SD=0.33933     t= 159.992
Stage I after mean   =3.1450 SD=0.77263  t=57.5661  p value=0.000
Table IV shows degree of pain in stage I before and after drug
administration in study group. In group I patients after drug
administration the pain score is decreased in stage I (p value-<0.0001).
              In group I, 23.5% of the patients had moderate pain relief and
38.5% of the patients had mild pain relief and 38% of patients had no
pain relief.
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TABLE V
PAIN IN STAGE II IN STUDY AND CONTROL GROUP
DEGREES OF PAIN
Group I Group II
No % No %
MILD(2-4) 0 0 0 0
MODERATE(5-7) 29 14.5 0 0
SEVERE(8-10) 171 85.5 200 100
TOTAL 200 100.0 200 100
Pearson Chi-Square =31.267, df =1,           p value=0.000
             Table V shows pain in stage II in study and control group. In
group I 85.5% of the patients had severe pain, 14.5% of the patients had
moderate pain. In group II all patients had severe pain. The pain in stage
II in  group I is less than  group II which is statistically significant(p
value-<0.001).
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Table VI
MEAN PAIN SCORE IN LABOUR
PAIN GROUP MEAN
STANDARD
DEVIATION
STAGE I
BEFORE
DRUG
STUDY 3.8680 0.33933
CONTROL 3.8550 0.35298
STAGE I
AFTER DRUG
STUDY 3.1450 0.77263
STAGE II
STUDY 3.8550 0.35298
CONTROL 4.0000 0.00000
Stage I       t=0.375 p=0.708
Stage II     t=-5.809 p=0.000
               Table VI shows mean pain score in labour in both groups. After
drug administration, the mean pain score is decreased in stage I and stage
II labour in group I patients than group II patients which are statistically
significant.
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TABLE VII
DURATION OF LABOUR
DURATION
OF LABOUR
IN MINUTE
GROUP NUMBER MEAN SD
P
value
STAGE I
STUDY 181 265.9392 64.06118
0.003
CONTROL 178 284.9888 56.28408
STAGE  II
STUDY 181 24.8950 11.85913
0.012
CONTROL 178 28.2135 12.89459
STAGE  III
STUDY 181 8.8398 3.36019
0.089
CONTROL 178 9.4382 3.27964
          Table VII shows duration of all three stages of labour in both
groups. Duration of Ist and IInd stages of labour is decreased in study
group than control group. Statistical significance showed in this table.
Duration of third stage of labour is not statistically significant.
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Table VIII
TOTAL DURATION OF LABOUR
TOTAL DURATION OF
LABOUR
Group I Group II
No % No %
< 200 MIN 12 6.0 2 1.0
201-250 MIN 48 24.0 27 13.5
251-300 MIN 52 26.0 37 18.5
301-350 MIN 36 18.0 61 30.5
>350 MIN 33 16.5 51 25.5
    Pearson Chi-Square=25.828, df =4, p value =0.000
Table VIII shows the total duration of labour in both groups. The
average total duration of labour in the group I is 290.21+/-65.43minutes.
The average total duration of labour in the group II is 320.55+/-
68.31minutes. The total duration of labour is less in group I patients than
group II patients.
         The Pearson chi-square test infers that there was a significant
difference between the two groups. By the above tests it was inferred that
in group I the duration was significantly shorter compared to group II.
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TABLE IX
MODE OF DELIVERY
MODE OF
DELIVERY
Group I Group II
No % No %
FTNVD 165 82.5 167 83.5
OUTLET
FORCEPS
15 7.5 11 5.5
LSCS 20 10.0 22 11.0
   Pearson Chi-Square=0.723,      df =2,               p value=0.697
Table IX shows the various modes of delivery in the two groups.
Majority of patients in group I (82.5%) had normal vaginal delivery,
83.5% of patients had normal vaginal delivery in groups II respectively.
The incidence of operative vaginal delivery is also equal in both groups.
The X2 statistical test was applied and it was inferred that the number of
patients who had normal vaginal delivery in both groups were statistically
not significant.
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TABLE X
INDICATION FOR INSTRUMENTAL DELIVERY
INDICATIONS
Group I Group II
No % No %
FTNVD 165 82.5 168 84.0
Outlet: Fetal Distress 7 3.5 5 2.5
Outlet: Maternal
Exhaustion
9 4.5 6 3.0
LSCS: fetal Distress 19 9.5 21 10.5
            Pearson Chi-Square=1.060,           df =3,           p value=0.787
         Table X shows the indications for instrumental vaginal delivery by
group. 82.5% and 84% of women in groups I and II delivered by normal
vaginal delivery. 3.5% of patients delivered by assisted vaginal delivery
in group I for second stage foetal distress. 2.5% of patients in group II
delivered by assisted vaginal delivery. Applying X2 statistical analysis
test, it was inferred that there was no difference in instrumental delivery
for fetal distress in both groups. . It was similar in the two groups.
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TABLE XI
BIRTH WEIGHT DISTRIBUTION
GROUP
Birth weight (KG)
S.D t test P value
Min Max Mean
I 2.1 3.8 2.8206 .43805
0.455 0.649
II 2.2 3.7 2.8016 .39548
              Table XI shows the birth weight by group. The mean birth
weight was 2.82±0.44 and 2.80±0.39 kilograms in group I and II
respectively and was statistically not significant. It was similar in the two
groups.
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TABLE XII
EFFECT ON IMMEDIATE FETAL OUTCOME
GROUP
Apgar at 1 minute Apgar at 5 minute
Min Max Mean  SD Min Max Mean SD
Group I 6 8 6.9550 1.07178 7 9 8.1000 .91882
Group II 6 8 7.0500 .98097 7 9 8.1900 .82297
Apgar at1minute t= 0.925 p value=0.356
Apgar at 2minute t= 1.032              p value=0.303
The table XII shows the immediate neonatal outcome in groups I
and groups II. In the majority of babies in both the groups the apgar score
was 7/10 at 1 min and 8/10 at 5 minutes. The t test infers that there was
no significant difference in the Apgar scores in the two groups. Both the
groups were similar and no statistically significant difference was noted
in the two groups.
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TABLE XIII
MATERNAL SIDE EFFECTS
ADVERSE EVENTS
Group I Group II
No % No %
NAUSEA 15 7.5 21 10.5
VOMITING 15 7.5     21 10.5
DROWSINESS 2 1.0 1 0.5
PALPITATION 0 0 0 0
HYPER SENSITIVITY 0 0 0 0
RESPIRATORY
DISTRESS
2 1.0 1 0.5
FETAL TACHYCARDIA 0 0 0 0
Table XIII shows maternal side effects by group. Nausea,
vomiting, drowsiness, respiratory distress are present in both groups.
Maternal side effects are similar in both groups.There was no difference
between the two groups in terms of the maternal side effects.
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TABLE XIV
MATERNAL COMPLICATIONS
GROUPS
VAGINAL TEAR
No %
I 29 14.5
II 28 14.0
             Table XIV shows maternal complications in groups I and II. The
maternal complications between the two groups were not statistically
significant. Maternal complications like vaginal tear are similar in both
groups. There was no difference between the two groups in terms of the
maternal complications
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TABLE XV
NUMBER OF MEDICATION IN THE STUDY GROUP
NO OF DOSES NO OF PATIENTS PERCENTAGE
1 150 75.0
2 50 25.0
TOTAL 200 100.0
         Table XV shows number of medications in the study group in
which75% of the patients required single dose and remaining of the
patients required two doses.
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TABLE XVI
DURATION OF HOSPITAL STAY
GROUPS 2-4 DAYS 5-7 DAYS >7 DAYS TOTAL
I 143 37 20 200
II 147 31 22 200
        Pearson Chi-Square=0.680, df =2,          p value=0.712
            Table XVI shows duration of hospital stay. Majority of the
patients in both groups required 2-4 days of hospital stay. The chi square
statistical test infers that duration distribution was similar in the two
groups. The range difference between the duration in groups of I and II
were statistically not significant. There was no difference between the
two groups in terms of duration of hospital stay.
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DISCUSSION
An ideal method for pain relief in labour should combine safety for
the mother and the foetus without any side effects and should be
convenient for the patient and the attendant physician. The present study
was designed to evaluate the efficacy of IM Tramadol Hydrochloride in
the late latent phase of first stage of labour.
The study randomised two groups of 200 pregnant women each
fulfilling the inclusion criteria.
Group I    – Patients treated with IM Tramadol in latent phase of labour.
Group II   – Patients who didn’t receive IM Tramadol in latent phase of
labour.
The two groups were standardised and compared regarding the
degree of pain relief, duration of labour, mode of delivery, fetal outcome,
maternal morbidity and hospital stay. The adverse effects of the drug on
the mother and newborn were noted.
AGE:
The present study had an age range of 18-35 years. 53% and 50.5%
of women were in age group of 21-25 years in groups I & II respectively.
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The difference in the age group among the two groups was not
statistically significant (p value – 0.691). There was an identical age
distribution in both the groups. This was to remove any effect of age on
degree of pain relief and duration of labour.
In the study by Thakur Ratna et al., 86 the mean age in years was 22
years. The mean age and the range of ages were statistically compatible
with the present study (Table I). Thus Age distribution was similar to the
present study.
GESTATIONAL AGE:
In the present study the gestational age, ranged between 37-40
weeks and above. 45% and 37.5% of women were in the gestational age
of 39.1 – 40 weeks in the groups I and II respectively (Table II). The
variation in the gestational age among the two groups was not statistically
significant (p-value=0.075).This was to remove any difference in the
degree of pain relief and duration of labour due to difference in the
gestational age.
The mean period of gestational age was 39 weeks in the study by
Nagaria Tripti et al., 83 and Sudha Patil et al., 84. The mean gestational age
and the range of gestational age were comparable with the present study.
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Similar to the study by Lie et al., 87 Viegas O A et al., 85 Jain  et  al.,  all
patients were Primigravida.
The measurement of degree of pain relief by visual analogue scale,
cervical effacement and dilatation, position of the cervix and the station
of the presenting part were observed by various qualified observers
randomly to avoid observer bias and findings were recorded on a
partogram. There was no significant difference in the effacement of the
cervix, dilatation of the cervix, station of the presenting part or the
position of the cervix in the two groups. Any bias relating to the above on
progress of labour has been removed.
DEGREE OF PAIN RELIEF:
Onset of pain relief in the present study was 15-20 minutes. Onset
of pain relief in the study by Nagaria Tripti et al., 83 and study by Sudha
Patil et al., 84 was 15-20 minutes. The same was present in this study.
In this study 23.5% of patients had moderate pain relief, 38.5% of
patients had mild pain relief and 38% of patients had no pain relief after
Tramadol administration. Before drug, the mean pain score is 3.86 in
stage I. After drug administration the mean pain score is 3.14 in stage I
and 3.81 in stage II.
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Degree of
pain relief
Sudha
patil
Thakur
ratna
Meena
jyothi
Nagaria
tripti
Sarkar b, Mukho-
padhyay
Present
study
Complete pain
relief
58% 15% 54% 37% 13% 0
Moderate pain
relief
30% 55% 32% 38% 38% 23.5%
Mild pain relief 12% 16% 14% 16% 45% 38.5%
No pain relief 12% 14% 0 9% 47% 38%
As shown in table V & VI, pain score is increased from stage I to
stage II in group I.14.5% of patients had moderate pain, 85% of patients
had severe pain. Only 85% of the study group experienced severe pain in
stage II. But 100% of patients in group II experienced severe pain. This
denotes statistical significance between the two groups.
This study is comparable to Sudha patil84, Thakur ratna86, Meena
jyothi82, Nagaria tripti83, Sarkar B.Mukhopadhyay et al75 studies.
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Bajaj et al., 88 conducted a randomised prospective study and
concluded that Tramadol gives 38.92% mean pain relief.
Jain et al., conducted a randomised control trial and compared IM
Opioids like Meperidine and Tramadol’s Analgesic efficacy with
Epidural Analgesia and concluded that Tramadol group patients had 65%
pain relief.
Li E87 and Weng studied the efficacy of Tramadol 100mg in latent
phase of labour and 67% of patients had pain relief in first stage of
labour.
O Kuti et al., 89 compared Tramadol with Pentazocine in labour
and concluded that mild pain relief present in 66% of patients, moderate
pain relief present in 30.9% of patients in Tramadol group.
Singh et al., 80 compared 100mg IM Tramadol with Pentazocine
and concluded that 80% of Tramadol group had moderate pain relief.
DURATION OF LABOUR:
The duration of latent phase of first stage of labour was calculated
from the onset of regular uterine contractions to the time of cervical
dilatation of 3-4cms.
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 In the present study the mean duration of first stage of labour in
group I is 265.93+/-64.066 min (Table VII). The mean duration of first
stage of labour in group II is 284.98+/-56.28 min. It was found that there
was a statistically significant shortening in the duration of first stage of
labour in the Tramadol group when compared to the control group (p
value – 0.003).
The duration of second stage of labour also significantly reduced in
group I compared to group II. No significant change was observed in the
duration of Third stage of labour in the control and study group. This
concluded that Tramadol will not prolong the Third stage of labour and
will not produce third stage complications.
Duration
of labour
Thakur
ratna et
al86
Nagaria
tripti et
al83
Khooshide
h m
alishahriari
69
Sudha patil
84
Present
study
STAGE 1
4.26+/-1.62
hours
4.28+/-2.22
hours
140 min
4.15 +/-
1.68 hours
265.93+/-
64.06 min
STAGE 2
11.95+/-
5.8min
0.30+/-0.05
hours
25 min
0.28
+/-0.42
hours
24.89+/-
11.85 min
STAGE 3
5.5+/-1.5
min
0.04+/-
0.015
hours
5.06+/-
0.56min
0.08+/-0.05
hours
8.83+/-
3.36min
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The average total duration of labour in group I is 290.21+/-65.43
min. The average total duration of labour in group II is 320.55+/-
68.31mins. The total duration of labour is significantly less in group I. As
shown in above table, all studies conducted by Thakur ratna et al86.,
Nagaria tripti et al83., Khooshideh m, ali shahriari69et al., Sudha patil et
al84., Mukhopadhyay AK75 ., Sarkar B ., Suvonnakote et al., concluded
that IM Tramadol reduces the duration of labour. It may be hence
summarised that Tramadol is effective in shortening the duration of
labour.
MODE OF DELIVERY
Mode of
delivery
Thakur
Ratna
et al 86
Nagaria
Tripti
et al83
O Kuti
et al 89
Sudha
Patil
84
Present
study
FTNVD 98% 93% 88.1% 90% 82.5%
LSCS 0 3% 9.5% 4% 10.0%
Instrumental
delivery
2% 4% 2.4% 6% 7.5%
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In the present study spontaneous vaginal delivery occurred in
82.5% of women in Tramadol group and 83.5% of women in control
group (Table IX). Only 7.5% in Group I and 5.5% in Group II had
instrumental vaginal delivery in the form of forceps application. The
indications were second stage foetal distress, 3.5% in Group I, 2.5% in
Group II and Maternal exhaustion 4.5% in Group I and 3% in Group II
(Table X).
The percentage of caesarean section was 10% in Group I and
10.5% in Group II. No significant difference was noted in the mode of
delivery in both groups.
NEONATAL OUTCOME:
BIRTH WEIGHT: The mean birth weight was 2.82+/-0.44 and
2.80+/-0.39 kg in Group I and II respectively. It was not statistically
significant, p value- 0.649 (Table XI).
This is to remove any influence of the mean birth weight on the
rate of cervical dilatation, cephalopelvic disproportion and dystocia
which would indirectly influence the duration of first stage of labour and
the total duration of labour.
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APGAR: The mean APGAR scores at 5minutes are 8.1+/-0.92 and
8.2+\-0.82 in Groups I and II respectively (Table XII). The difference
among the two groups was not statistically significant (p value = 0.303).
 In the Bajaj P et al., study, the Apgar score was 8-10 at 5minutes
in all the babies. The result of the referral study was comparable to the
present study, which indicates that the drugs have no effect on the foetus.
MATERNAL SIDE-EFFECTS:
Side Effects
Thakur
Ratna et
al86
Nagaria
Tripti
et al83
O
Kuti
et al89
Bajaj P
et al88
Khooshideh
et al 69
Present
study
Nausea 7% 11% - 22.2% 15% 7.5%
Vomiting 3% 4% 2.4% - - 7.5%
Drowsiness 2% 1% 14.3% 11.11% 29% 1.0%
Palpitation 1% - - - - -
Hyper
sensitivity
- - - - - -
Dry mouth 10% - - - - -
The various side-effects observed were Nausea, Vomiting and
Drowsiness. All these maternal side-effects are similar in both groups
(Table XIII). It concluded that Tramadol will not produce any adverse
effects.
92
MATERNAL COMPLICATIONS:
Of the maternal complications, vaginal tear was noted in 29 and 28
patients in group I & II (table XIV). No difference was noted between the
two groups in terms of maternal complications.
NUMBER OF DOSES REQUIRED:
75% of the patients in the study group required only a single dose
and 25% of the patients required a second dose (Table XV). No study
observed the number of doses required and hence no comparison between
referral studies was attempted.
DURATION OF HOSPITAL STAY:
Majority of the patients in both groups required 2-4 days of
hospital stay. The range difference between the duration of hospital stay
in groups I and II were statistically not significant. There was no
difference between the two groups in terms of duration of hospital stay.
This concludes that Tramadol does not have any influence in duration of
hospital stay.
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SUMMARY
This prospective study was undertaken in the Department of
Obstetrics and Gynaecology, Stanley Medical College, RSRM Lying-in
Hospital during the period of October 2012 to November 2013.
400 Women who were in late latent phase of first stage of labour
were selected for the study. They were randomly divided into two groups.
Group I- consisted of 200 women who were given 100 mg IM Tramadol
in late latent phase of labour and second dose was repeated after 2hours
in patients with severe pain who were not entered into the second stage.
Group II- consisting of 200 women served as control.
This study was conducted with the aim of proving that IM
Tramadol Hydrochloride was effective in pain relief in first stage of
labour and it also shortened the duration of labour.
In this study,
? Majority of women were between 21-25 years of age. Majority
were found to be between 39.1-40 weeks of gestation. There was
no statistically significant difference in the age distribution and
gestational age among the two groups.
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? Numerical Pain Intensity Scale was used to assess the degree of
pain relief.
? After Tramadol administration the pain score in Stage I was
significantly reduced (p value <0.0001).
? In this study 23.5% of patients had moderate pain relief, 38.5% of
patients had mild pain relief and 38% of patients had no pain relief
after Tramadol administration. Before drug, the mean pain score is
3.86 in stage I. After drug administration the mean pain score is
3.14 in stage I and 3.81 in stage II.
? Pain score is increased from stage I to stage II in group I. 14.5% of
patients had moderate pain, 85% of patients had severe pain. Only
85% of the study group experienced severe pain in stage II. But
100% of patients in group II experienced severe pain. This denotes
statistical significance between the two groups.
? The Mean duration of first stage of labour was 265.93+/-64.06 and
284.98+/-56.28 minutes in group I & II respectively (p
value=0.003). The Mean duration of second stage of labour was
24.89+/-11.86 and 28.21+/-12.89 in groups I & II respectively (p
value= 0.012).  There was a statistically significant shortening in
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the duration of first and second stage of labour. The duration of
third stage of labour was not significantly different among the two
groups.
? The total duration of labour was 290.21+/-65.43 and 320.55+/-
68.31 minutes in groups I & II. The total duration was significantly
shorter in group I (p value <0.0001).
? No significant difference was noted in the mode of delivery in both
groups.
? Neonatal outcome was not different in two groups. There were no
cases of perinatal mortality or admission to Neonatal Intensive
Care Unit.
? Maternal side-effects like nausea, vomiting and drowsiness are
similar in both groups. Hence statistically not significant.
? Maternal morbidity, duration of hospital stay and number of
medication required were not increased in group I.
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CONCLUSION
1) IM Tramadol Hydrochloride is effective in pain relief in first stage
of labour and also it shortens the duration of first & second stage of
labour.
2) Tramadol didn’t affect the duration of third stage of labour.
3) Tramadol caused no major increase in instrumental or caesarean
section rates.
4) Tramadol had no significant maternal or fetal side effect. It was
found to be safe for both mother and baby.
5) Tramadol didn’t increase maternal morbidity and duration of
hospital stay; hence the drug is cost effective.
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SUGGESTION
Further studies in IM Tramadol Hydrochloride to decrease the pain
score and duration of First Stage of Labour, to improve the fetal outcome
and to decrease the Maternal Morbidity, should be instituted to enable
this drug to be included in first line protocol in management of First
Stage of Labour.
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PROFORMA
Sl.No. IP No.
Name: Date of Admission & Time:
W/o: Date of Delivery & Time   :
Age: Booked / Unbooked        :
Occupation:
Address:
Chief Complaints:
History of present Illness: H/o………………. Amenorrhea
C/o Labour pains -------------- hrs
H/o Leak PV/Bleeding PV------hrs
Other complaints
Menstrual History: LMP:                           EDD:
Previous Menstrual Cycle: Menarche:
Regular/Irregular
Days flow
Duration of Cycle                                     Associated complaints
Obstetric History: Primigravida 1st Trimester
                2nd Trimester
     3rd Trimester
Past History:     HTN/DM/TB/Asthma/Heart Disease/Drug Allergy
Family History: HTN/DM/TB/Asthma/Heart Disease/Dug Allergy
Personal History:
Diet: Bowel:
Appetite: Bladder:
Sleep: Habits:
General Physical Examination: Height_______ Cms Weight____ Kgs
Built___________  Nourishment ____________________
Vital Data: Pulse: General examination: Pallor:
               BP:                            Icterus:
     Temp:                                      Pedal Edema:
     RR:                            Lymphadenopathy:
                           Thyroid swelling:
Systemic Examination: CVS:
RS:
CNS:
Obstetric Examination:
P/A Uterus___________________ wks: Acting/Relaxed/Irritable
Longitudinal lie/cephalic presentation                            EFW:
Head_____________________
FHR_________________
Clinically Liquor Adequate
PV: Cervix
Dilatation
Membranes Present/Absent
Liquor color:
Vx Station:
Pelvic Assessment:
Investigation: Hb% Urine: Albumin
Blood group & Rh-typing Sugar:
HIV, VDRL, HbsAg           Microscopy:
RBS          Urea           Creatinine
CTG
Ultra sonogram:
BPD:
FL:
HC:
AC:
PLACENTA:
LIQUOR:
Administration of the drug
Before After (Second hourly)
Contractions
FHS
Administration of the drug
Before After (Second hourly)
Dilatation
Length
Position
Consistency
Station
Membranes
Degree of pain after drug administration by NPI Scale
                 1st Stage 2ndStage
Grade-1      No pain
Grade-II     Mild pain but comfortable
Grade-III    Moderate pain with discomfort
Grade-IV    Severe pain/maximum pain
Mode of delivery
Vaginal delivery (Episiotomy/Outlet Forceps/Vacuum
extraction/LSCS)
           Placenta + Membrane weight:
Time taken for the delivery
1st Stage
2nd Stage
3rd Stage
Total duration of labour
Drug delivery interval
Neonatal outcome:
Live born:                Born alive & Dead                  Still born
APGAR-1’               5’                    8’                   10’
 Sex of baby                        M/F
Birth wt in kg
Neonatal morbidity           Yes      No
Admission to NICU:         Yes      No
Reason:
Duration of admission:
Condition at discharge:
Adverse Effect of Drugs:
Nausea Vomiting RespiratoryDepression
Fetal
tachycardia/
Bradycardia
Present/Absent Present/Absent Present/Absent Present/Absent
Name & Signature of Guide
Professor
Dept. of OG
Stanley Medical College,
Chennai
Name & Signature of PG
Date:
Time: Name & Signature of
Co/Guide

ABBREVIATIONS USED
APH        - Ante Partum hemorrhage
ACOG     - American College of Obstetrics and Gynaecology
ACTH     - Adreno Cortico Tropic Hormone
AP           - Apgar
10 -1 minute
50 -5 minute
B.W.        - Birth Weight
BP           - Blood Pressure
C             -Control
CPD        -Cephalo Pelvic Disproportion
CTG        - Cardio Toco Gram
FD           - Fetal Distress
FTNVD   - Full Term Normal Vaginal Delivery
GA          - Gestational Age
HS           - Hospital Stay
IM           - Intra Muscular
I V           - Intra Venous
LSCS       - Lower Segment Caesarean Section
MC          - Maternal Complication
ME          - Maternal Exhaustion
NPI          - Numeric Pain Intensity Scale
NSAIDS  - Non Steroidal Anti Inflammatory Drugs
PS           - Pain Score
SD          - Standard Deviation
TENS      - Trans Cutaneous Electric Nerve Stimulation
VAS        - Visual Analogue Scale
VT          - Vaginal Tear
VRS        - Verbal Rating Scale

354 Valliammal 26 4449 39+5 1 10 9 7 300 24 6 330 FTNVD 1  3 NO NO NO NO 7 8 VT 5 
355 Saraswathy 20 4470 40+5 2 10  10 280 20 10 310 0UTLET  ME 2.7 NO NO NO NO 7 8 VT 5 
356 Nirsha 21 4497 39+3 1 9 10 10 200 33 7 240 OUTLET 1 ME 3.5 NO NO NO NO 7 8 VT 5 
357 Pushpalatha 21 4501 39+1 2 10  9 260 15 10 285 FTNVD   2.8 NO NO NO NO 7 9  3 
358 Lakshmi 19 4512 39+2 2 9  9 230 20 10 260 FTNVD   3 NO NO NO NO 7 8  3 
359 jayalakshmi 25 4530 38+1 1 9 3 10 260 15 5 280 FTNVD 1  2.3 NO NO NO NO 8 8  3 
360 Asima 22 4561 38+5 1 9 3 9 240 35 5 280 FTNVD 1  2.75 NO NO NO NO 7 8  3 
361 Valli 19 4586 40 2 10  10 320 30 10 360 FTNVD   3.3 NO NO NO NO 7 8  3 
362 Nalini 23 4599 37+6 2 10  10 240 15 5 260 FTNVD   3.2 NO NO NO NO 7 8  3 
363 Maythili 19 4620 38+5 1 9 4 8 300 40 20 360 FTNVD 2  2.1 YES NO NO NO 7 8  3 
364 Devi 20 4635 38+1 2 10  10 260 25 10 295 FTNVD   2.5 NO NO NO NO 7 9  3 
365 Sangeetha 24 4650 39+3 1 9 6 10 310 25 10 345 FTNVD 2  2.65 NO NO NO NO 6 7  3 
366 Valli 25 4682 39+1 2 10  9 300 55 10 365 FTNVD   2.4 NO NO NO NO 7 9  3 
367 Vijaylakshmi 25 4700 39+1 1 8 6 8     LSCS 1 FD 2.6 NO NO NO YES 7 8  8 
368 Bhavani 19 4721 38+5 1 10 5 10 220 17 13 250 FTNVD 1  2.75 NO NO NO NO 7 7  3 
369 Gayathri 21 4735 38+1 1 9 6 9 360 38 12 410 FTNVD 2  2.55 NO NO NO NO 7 8  3 
370 Jamuna 19 4762 38+5 2 10  10 240 28 12 280 FTNVD   2.4 NO NO NO NO 7 9  3 
371 Dhanalakshmi 23 4785 38+1 1 10 9 10 300 19 13 332 FTNVD 2  2.7 NO NO NO NO 7 8  3 
372 Yamuna 19 4802 39 1 9 8 10 320 30 10 360 FTNVD 2  3.2 NO NO NO NO 7 8  3 
373 Renuka 26 4830 38+2 2 10  10 200 20 10 230 OUTLET  ME 2.4 NO NO NO NO 7 9 VT 5 
374 Deepa 25 4861 39+2 1 9 8 7 180 25 10 215 FTNVD 1  3.2 NO NO NO NO 7 8  3 
375 Roja 20 4885 39+5 2 10  9 360 26 14 400 FTNVD   3.2 NO NO NO NO 7 9  3 
376 Nagavalli 25 4896 40+1 1 9 8 8     LSCS 1 FD 3.2 YES NO NO NO 7 8  8 
377 Revathy 22 4912 39+1 2 8  9     LSCS  FD 2.2 NO NO NO NO 7 9  8 
378 Prabahavathy 20 4931 38+3 1 9 6 10 300 28 12 340 FTNVD 1  3.45 NO NO NO NO 7 9 VT 5 
379 Deepa 22 4951 39+2 1 10 6 8 360 20 10 390 FTNVD 1  2.95 YES NO NO NO 7 9  3 
380 Ramya 27 5346 38+1 1 10 6 9 280 10 5 295 FTNVD 1  2.75 NO NO NO NO 7 9  3 
381 Sreedevi 29 5368 38+6 1 10 6 10 340 30 10 380 FTNVD 2  3.2 NO NO NO NO 7 8  3 
382 Rupavadi 19 5365 39+1 2 8  9 220 10 10 240 FTNVD   2.75 NO NO NO NO 7 9  3 
383 Prema 23 5399 38+2 2 8  9 270 30 15 315 FTNVD   2.25 NO NO NO NO 8 9  3 
384 Poovizhi 20 5401 39+1 1 7 7 10     LSCS 1 FD 2.9 NO NO NO NO 7 8  8 
385 Shivaranjani 21 5415 38+6 2 9  9     LSCS  FD 2.6 NO NO NO NO 7 9  8 
386 Suleha 23 5462 39+2 2 10  9 270 25 5 300 FTNVD   3.5 NO NO NO NO 8 9  3 
387 Seetha 21 5480 38+6 2 9  10     LSCS  FD 3.5 YES NO NO NO 7 8  8 
388 Buvaneshwari 23 5491 39+3 2 9  8     LSCS  FD 2.25 NO NO NO NO 6 7  8 
389 Kanimozhi 21 5503 39+1 1 10 7 10 260 24 6 290 FTNVD 1  2.75 NO NO NO NO 7 8  3 
390 Sussikala 25 5515 39+6 1 8 10 7     LSCS 1 FD 3.3 NO NO NO NO 7 8  8 
391 Sangeetha 21 5540 39+2 1 10 9 8 240 25 10 275 FTNVD 1  3 NO NO NO NO 7 9  3 
392 Vidyavathi 31 5557 37+1 2 10  8 310 17 5 332 FTNVD   2.8 YES NO NO NO 7 7  3 
393 Padmavathi 25 5590 40 2 9  8     LSCS  FD 2.7 NO NO NO NO 6 8  8 
394 Hemavathi 21 5601 39+5 1 9 8 10 200 25 5 230 FTNVD 1  2.6 NO NO NO NO 7 9  3 
395 Inbailavarasi 27 5612 38+3 2 10  8 320 60 10 390 FTNVD   3.5 NO NO NO NO 7 8  3 
396 Suganya 21 5617 37+2 1 10 9 9 400 25 5 430 FTNVD 1  3.5 NO NO NO NO 7 9  3 
397 Sangeetha 24 5623 39+3 1 9 10 8 240 12 8 260 FTNVD 1  3.45 NO NO NO NO 8 9  3 
398 Priyamani 22 5637 37+4 1 10 10 10 280 30 7 317 FTNVD 1  3 NO NO NO NO 6 9  3 
399 Nandhini 21 5639 40+3 2 9  8 220 25 10 255 OUTLET  FD 2.2 NO NO NO NO 8 8 VT 5 
400 Vasanthi 18 5640 39+6 1 9 10 7 280 15 10 305 FTNVD 1  2.75 NO NO NO NO 6 9  3 
 
303 swapna 18 3547 39+4 1 9 9 8 280 30 7 317 FTNVD 1  3 NO NO NO NO 6 7  3 
304 priya 20 3513 38+6 1 9 8 9 220 25 10 255 FTNVD 1  2.2 NO NO NO NO 8 8 VT 5 
305 revathy 20 3592 37+1 2 9  10 280 15 10 305 FTNVD   2.75 NO NO NO NO 6 7 VT 5 
306 dhivya 20 3638 39+2 1 9 10 7 290 13 5 308 FTNVD 1  2.8 NO NO NO NO 7 8  3 
307 vennila 20 3627 40+5 2 9  9 310 35 5 350 FTNVD   2.75 NO NO NO NO 7 7  3 
308 surya 20 3442 38+1 1 10 7 10 200 10 5 215 FTNVD 1  3.2 NO NO NO NO 6 9  3 
309 padmapriya 23 3683 40+1 1 10 7 10 180 10 4 194 FTNVD 1  3.5 YES NO NO NO 7 9  3 
310 revathy 20 3689 37+3 2 10  10 220 25 10 255 FTNVD   2.3 NO NO NO NO 7 7  3 
311 nirmala 22 3685 39+5 1 9 7 8 280 30 10 320 FTNVD 2  2.5 NO NO NO NO 7 9 VT 5 
312 subha 22 3723 39+4 1 9 7 10 290 18 5 313 FTNVD 1  2.8 NO NO NO NO 7 9  3 
313 poongodi 23 3611 38+6 2 10  9 280 15 5 300 FTNVD   2.7 NO NO NO NO 7 7  3 
314 sudha 23 3764 39+1 1 9 7 9 270 15 5 290 FTNVD 1  3.3 NO NO NO NO 7 9  3 
315 Maheshwari 21 3806 38+2 1 10 7 7 320 65 10 395 FTNVD 1  3.2 NO NO NO NO 8 9  3 
316 vijayalakshmi 20 3799 37+2 2 8  9 300 18 12 330 FTNVD   2.6 YES NO NO NO 7 7  3 
317 saranya 20 3786 37+6 2 10  10 320 25 5 350 FTNVD   2.9 NO NO NO NO 6 7  3 
318 grace 24 3745 39+2 1 10 7 10 200 15 5 220 OUTLET 1 FD 3 NO NO NO NO 8 9 VT 5 
319 susila 22 3866 37+2 2 10  10 320 45 10 375 FTNVD   2.55 NO NO NO NO 6 7  3 
320 Megala 18 3830 38+4 2 10  10 200 18 10 228 FTNVD   3.2 NO NO NO NO 7 7  3 
321 kalaimathypriya 24 3885 38+4 2 10  9 300 44 18 362 FTNVD   2.7 NO NO NO NO 7 8  3 
322 sharmila 20 3861 38+4 1 10 7 9 270 15 5 290 FTNVD 1  3.1 NO NO NO NO 7 8  3 
323 banu 18 3908 38+6 2 10  10 210 21 7 238 FTNVD   2.56 NO NO NO NO 7 8  3 
324 nalini 20 3889 40+2 1 9 7 7 300 18 6 324 FTNVD 2  2.8 NO NO NO NO 8 7  3 
325 malathy 26 3961 37+2 2 10  9 230 32 10 272 FTNVD   3.5 NO NO NO NO 6 7  3 
326 kamatchi 23 3976 39 2 9  10 220 30 5 255 FTNVD   2.9 NO NO NO NO 6 8  3 
327 priya 22 3983 38+2 1 10 10 8 200 20 5 245 FTNVD 1  2.7 NO NO NO NO 7 8  3 
328 sowmiya 20 3955 39+4 2 10  9 300 49 7 356 FTNVD   2.7 NO NO NO NO 7 8  3 
329 deepika 22 3993 37+2 1 10 9 10 420 40 10 470 FTNVD 1  3 NO NO NO NO 8 7  3 
330 jayachitra 21 3950 40 1 9 8 10 180 10 10 200 FTNVD 1  2.9 NO NO NO NO 7 8  3 
331 punitha 24 3986 39+1 2 10  10 360 31 17 408 OUTLET  ME 2.5 NO NO NO NO 7 8 VT 5 
332 azhagurani 18 4029 38+2 2 9  9 280 24 12 316 FTNVD   2.6 NO NO NO NO 7 8  3 
333 joy 19 4061 39+1 2 9  10 240 20 5 265 FTNVD   3 NO NO NO NO 7 8  3 
334 Mariya 20 4095 37+5 1 10 8 8 375 65 10 450 FTNVD 2  2.5 NO NO NO NO 7 8  3 
335 Kowsalya 20 4108 38+3 1 10 10 10 180 15 10 205 FTNVD 1  2.75 NO NO NO NO 7 8  3 
336 Subathra 20 4125 39+6 2 10  9 360 30 10 400 FTNVD   3.2 YES NO NO NO 6 9  3 
337 bharathy 25 4142 39 2 10  10 210 20 10 240 FTNVD   2.6 NO NO NO NO 7 8  3 
338 Muthurani 18 4160 38+2 1 10 8 9 380 45 20 445 FTNVD 2  3 NO NO NO NO 8 9  3 
339 Shaina banu 20 4184 40+2 1 10 7 7 380 28 10 418 OUTLET 2 FD 2.75 NO NO NO NO 7 9  5 
340 Nasseer fathima 24 4200 40 2 10  9 260 22 10 292 FTNVD   2.25 NO NO NO NO 7 8  3 
341 Ashifa 25 4217 39+4 2 10  10 400 38 18 456 FTNVD   3 NO NO NO NO 6 9  3 
342 Geetha 20 4230 39+3 1 10 7 10 420 40 10 470 FTNVD 2  2.8 NO NO NO NO 8 9  3 
343 Vetriselvi 21 4246 39+2 1 9 7 10 320 46 8 374 FTNVD 2  2.9 NO NO NO NO 7 9 VT 5 
344 Annaporni 25 4264 39+2 2 10  10 240 30 10 280 FTNVD   3.25 NO NO NO NO 7 9  3 
345 Mariammal 21 4281 40+2 1 10 10 9 290 26 5 321 FTNVD 1  2.9 NO NO NO NO 8 9 VT 5 
346 Gayathri 20 4300 39+1 2 10  9 280 20 10 310 FTNVD   2.8 YES NO NO NO 7 9  3 
347 Raji 21 4315 38 1 9 7 10 320 65 10 395 FTNVD 2  3 NO NO NO NO 8 9  3 
348 bharathy 20 4331 39+4 1 8 10 8 240 19 7 266 FTNVD 1  2.75 NO NO NO NO 7 8  3 
349 Snadhiya 20 4350 37+6 2 9  9     LSCS  FD 2.4 NO NO NO NO 7 9  8 
350 Rajeshwari 35 4371 38 1 10 7 8 200 26 8 234 FTNVD 1  2.65 NO NO NO NO 8 7 VT 5 
351 Shanmuga priya 21 4394 38+3 2 10  9 220 20 10 250 FTNVD   2.6 NO NO NO NO 7 9  3 
352 Mohanambal 25 4402 38+2 1 10 8 9 270 21 17 308 OUTLET 1 FD 2.9 NO NO NO NO 7 8  5 
353 Geetha 22 4421 39+1 2 10  10 335 48 10 393 FTNVD   2.5 NO NO NO NO 7 9 VT 5 
252 Vasugi 23 7283 38+2 2 9  10 320 65 10 395 OUTLET  FD 3 NO NO NO NO 7 9  5 
253 Rajakumari 20 7295 38+2 1 8 7 10 240 19 7 266 FTNVD 1  2.75 NO NO NO NO 7 7 VT 5 
254 Muthulakshmi 28 7306 39+4 1 8 8 8     LSCS 1 FD 2.4 NO NO NO NO 7 8  8 
255 Kathabeevi 26 7315 40+1 1 10 8 9 200 26 8 234 FTNVD 1  2.65 NO NO NO NO 6 8  3 
256 Malathy 28 7335 39+3 1 10 8 10 220 20 10 250 FTNVD 1  2.6 NO NO NO NO 7 8  3 
257 Suba 24 7350 38+4 1 10 10 7 270 21 17 308 OUTLET 1 FD 2.9 NO NO NO NO 7 8  5 
258 Anushya 25 7372 40+1 1 10 7 9 335 48 10 393 FTNVD 2  2.5 NO NO NO NO 7 8  3 
259 Reemarosi 25 7390 40+3 1 10 5 8 300 24 6 330 FTNVD 1  3 NO NO NO NO 7 8  3 
260 Vanitha 20 7400 39+2 2 10  9 280 20 10 310 FTNVD   2.7 NO NO NO NO 7 9  3 
261 Deivanayagi 23 7415 38+1 1 9 6 8 200 33 7 240 OUTLET 1 ME 3.5 NO NO NO NO 7 8  5 
262 Deepavalli 24 7433 38+2 1 10 6 9 260 15 10 285 FTNVD 1  2.8 NO NO NO NO 7 8  3 
263 Selvi 26 7448 39+6 1 9 6 10 230 20 10 260 FTNVD 1  2.7 NO NO NO NO 7 7  8 
264 Jothy 28 7460 38+2 1 9 6 9 260 15 5 280 FTNVD 1  2.3 NO NO NO NO 8 7  3 
265 Revathy 29 7495 38+6 1 9 7 10 240 35 5 280 FTNVD 1  2.75 NO NO NO NO 7 7  8 
266 Shanthy 22 7506 40+4 1 10 7 9 320 30 10 360 FTNVD 1  3.3 NO NO NO NO 7 7  3 
267 Elaiyarsi 20 7530 40+2 2 10  9 240 15 5 260 FTNVD   3.2 NO NO NO NO 7 9  3 
268 Sathya 20 7546 38+2 1 9 10 10 300 40 20 360 FTNVD   2.2 YES NO NO NO 7 9  8 
269 Megaladevi 23 7570 37+2 2 10  9 260 25 10 295 FTNVD   2.5 NO NO NO NO 7 9  3 
270 Manjula 26 7592 38+1 1 10 7 9 310 25 10 345 FTNVD 2  2.65 NO NO NO NO 6 7  3 
271 Usharani 25 7603 39+6 2 10  10 300 55 10 365 FTNVD   2.4 NO NO NO NO 7 9  3 
272 Suba 28 7620 41+4 1 8 7 7     LSCS 1 FD 2.6 NO NO NO YES 7 8  8 
273 Bhuvaneeshwari 29 7638 38+4 1 10 7 8 220 17 13 250 FTNVD 1  2.75 NO NO NO NO 6 8  3 
274 Kahar beevi 20 7650 38+2 1 9 10 8 360 38 12 410 FTNVD 2  2.55 NO NO NO NO 7 8 VT 5 
275 Ajantha 23 7778 39+5 2 10  10 240 28 12 280 FTNVD   2.4 NO NO NO NO 7 9  3 
276 Vimala 26 7709 38+2 2 10  9 300 19 13 332 FTNVD   2.7 NO NO NO NO 7 8  3 
277 Kalayarasi 20 7734 38+6 2 9  10 320 30 10 360 FTNVD   3.2 NO NO NO NO 7 8  3 
278 Kanimozhi 29 7790 39+5 1 10 10 10 200 20 10 230 OUTLET 1 ME 2.4 NO NO NO NO 7 8  5 
279 Rajavizhi 26 7793 39+6 1 8 7 10 180 25 10 215 FTNVD 1  3.2 NO NO NO NO 7 8  3 
280 Rajkumari 25 7799 38+1 2 10  9 360 26 14 400 FTNVD   3.2 NO NO NO NO 7 7  3 
281 Vembu 27 7712 39+5 1 9 10 9     LSCS 1 FD 3.2 YES NO NO NO 7 8  8 
282 Sarala 20 7738 38+5 2 9  10     LSCS  FD 2.2 NO NO NO NO 7 8  8 
283 Jeyanthi 19 7713 37+3 2 9  9 300 28 12 340 FTNVD   3.45 NO NO NO NO 7 8 VT 5 
284 Malathy 28 7715 39+2 1 10 8 7 360 20 10 390 FTNVD 1  2.95 YES NO NO NO 7 8  3 
285 Kavitha 26 7723 39+1 1 10 10 8 280 10 5 295 FTNVD 1  2.75 NO NO NO NO 7 8  3 
286 Vasanthy 25 7726 38+1 1 9 3 8 340 30 10 380 FTNVD 2  3.2 NO NO NO NO 7 8  3 
287 Indraleka 29 7789 38+3 2 9  10 220 10 10 240 FTNVD   2.75 NO NO NO NO 7 8  3 
288 Shanthy 28 7780 38+6 2 8  10 270 30 15 315 FTNVD   2.25 NO NO NO NO 8 8 VT 5 
289 Nalini 27 7765 39+2 1 9 4 10     LSCS 1 FD 2.9 NO NO NO NO 7 8  8 
290 Suriya 26 7745 38+6 2 9  9     LSCS  FD 2.6 NO NO NO NO 6 8  8 
291 jothylakshmi 22 7743 39+2 1 10 4 8 270 25 5 300 FTNVD 1  3.5 NO NO NO NO 6 7  3 
292 Revathy 24 7744 38+3 2 9  10     LSCS  FD 3.5 YES NO NO NO 7 8  8 
293 ganamani 23 7801 37+6 1 9 4 8     LSCS 1 FD 2.25 NO NO NO NO 6 7  8 
294 bhuvaneshwari 25 7888 38+5 2 10  9 260 24 6 290 FTNVD   2.75 NO NO NO NO 7 8  3 
295 jebila 18 3271 38+3 1 8 4 9     LSCS 1 FD 3.3 NO NO NO NO 7 8  8 
296 nadhiya 21 3528 39+1 2 10  10 240 25 10 275 FTNVD   3 NO NO NO NO 7 8  3 
297 bharathy 28 3529 38+4 2 10  9 310 17 5 332 FTNVD   2.8 YES NO NO NO 7 7 VT 5 
298 gayathri 25 3530 38+4 2 9  10     LSCS  FD 2.7 NO NO NO NO 6 7  8 
299 devi 28 3535 40 1 9 4 9 200 25 5 230 FTNVD 1  2.6 NO NO NO NO 7 8  3 
300 geetha 21 3559 38+6 1 10 4 7 320 60 10 390 FTNVD 1  3.5 NO NO NO NO 7 8  3 
301 sulochana 22 3562 38+4 2 9  9 400 25 5 430 FTNVD   3.6 NO NO NO NO 7 7  3 
302 sulthana 22 3557 39+4 1 9 8 10 240 12 8 260 FTNVD 1  3.45 NO NO NO NO 8 9  3 
201 Prabahavathy 21 6176 37+5 1 9 9 8 240 15 10 265 FTNVD 1  3 NO NO NO NO 8 7  3 
202 Janatha 26 6179 38+3 2 10  9 220 30 10 250 FTNVD   3 NO NO NO NO 6 9  3 
203 Sumathy 20 6180 39+6 1 9 9 9 260 10 10 280 FTNVD 1  3.2 NO NO NO NO 8 7  3 
204 Sridevi 19 6181 39 2 9  10 280 60 10 350 FTNVD   3 NO NO NO NO 7 9  3 
205 Muthulakshmi 23 6183 38+2 2 9  10 240 10 4 254 FTNVD   3.5 NO NO NO NO 7 9  3 
206 Malathy 26 6190 40+2 1 9 7 7 320 15 10 345 FTNVD 2  2.74 NO NO NO NO 8 7  3 
207 Kalyani 27 6203 40 1 9 7 9     LSCS 1 FD 2.6 NO NO NO NO 8 7  8 
208 Dhanapriya 28 6214 39+4 2 10  9     LSCS  FD 2.4 NO NO NO NO 7 9  8 
209 Gomathy 23 6321 39+3 2 10  10 280 63 7 350 FTNVD   2.75 NO NO NO NO 6 9  3 
210 Uma maheshwari 28 6527 39+2 2 10  10 270 33 7 310 FTNVD   3.1 NO NO NO NO 6 9  3 
211 Chitra 29 6666 39+2 1 9 9 10 250 23 10 283 FTNVD 1  2.8 NO NO NO NO 8 7  3 
212 Anita 26 6689 40+2 1 8 8 8 240 10 5 255 FTNVD 1  2.5 NO NO NO NO 8 7  3 
213 Vijaya 30 6693 39+1 2 9  9 280 20 5 305 FTNVD   2.4 YES YES NO NO 6 9  3 
214 Amudha 29 6721 38+2 1 9 8 10 420 65 15 500 FTNVD 2  2.76 NO NO NO NO 8 7 VT 5 
215 Sundari 24 6735 39 2 10  9 420 60 10 490 FTNVD   3 NO NO NO NO 6 9  3 
216 Rajavalli 21 6787 40+2 1 8 7 9 270 30 10 310 FTNVD 2  2.9 NO NO NO NO 8 7  3 
217 Selvarani 28 6793 40+1 2 10  9 200 20 8 228 FTNVD   2.5 NO NO NO NO 6 9  3 
218 Sudha sri 24 6800 39+4 1 10 7 8 280 21 8 309 FTNVD 1  2.54 NO NO NO NO 8 7 VT 5 
219 Kalaiselvi 27 6811 39+5 1 10 7 10 225 29 7 261 FTNVD 1  2.4 NO NO NO NO 8 7  3 
220 Kaviya 26 6821 39+6 1 10 7 7 220 20 8 248 FTNVD 1  2.8 NO NO NO NO 8 7 VT 5 
221 Kavin 25 6847 38+1 2 10  10 170 20 10 200 FTNVD   2.56 NO NO NO NO 6 8  3 
222 Hajima 20 6872 39+2 1 9 7 9 260 10 10 280 FTNVD 1  2.45 NO NO NO NO 8 7  3 
223 Mary 24 6894 38+1 2 10  9 280 60 10 350 FTNVD   2.8 NO NO NO NO 6 7  3 
224 Sheeba 26 6911 38+6 1 9 7 10 240 10 4 254 FTNVD 1  2.75 NO NO NO NO 8 7  3 
225 Lavanya 18 6932 38+4 1 9 9 8 320 15 10 345 FTNVD 1  3.4 NO NO NO NO 8 8 VT 5 
226 Pushpa 23 6941 40+5 2 10  10 300 20 10 330 FTNVD   2.8 NO NO NO NO 6 8  3 
227 Thangam 28 6952 40 2 10  10 200 15 5 220 FTNVD   3.1 NO NO NO NO 6 8  5 
228 Thamarai 24 6961 39+2 1 9 9 9 190 20 8 218 OUTLET 1 ME 2.8 NO NO NO NO 8 9  5 
229 Amritha 25 6972 39+2 2 10  10 280 38 10 328 FTNVD   2.5 NO NO NO NO 7 8 VT 5 
230 Deepa 21 6990 40+2 2 10  10 300 40 10 350 FTNVD   2.4 NO NO NO NO 7 8  3 
231 Mangayarkarasi 23 7005 39 1 9 3 10 220 30 5 255 FTNVD 1  2.9 NO NO NO NO 6 8 VT 5 
232 Kayalvizhi 18 7020 37 2 9  9     LSCS  FD 2.7 NO NO NO NO 7 7  8 
233 Jayanthi 28 7045 38 2 10  9 300 49 7 356 FTNVD   2.5 NO NO NO NO 7 8  3 
234 Nirmala 24 7060 39 2 10  9 420 40 10 470 FTNVD   3 NO NO NO NO 6 9  3 
235 Kanagavalli 27 7080 38+3 1 9 3 8 180 10 10 200 FTNVD 1  2.9 NO NO NO NO 7 8  3 
236 Selvi 31 7106 40+3 2 10  9 360 31 17 408 FTNVD   2.5 NO NO NO NO 7 9  3 
237 Parvathy 26 7025 39+5 2 9  9 280 24 12 316 FTNVD   2.6 NO NO NO NO 7 9  3 
238 Vatchala 21 7048 37+4 1 9 4 8 240 20 5 265 FTNVD 1  3 NO NO NO NO 7 9  3 
239 Simathy 26 7059 40+3 2 10  9 375 65 10 450 FTNVD   2.5 NO NO NO NO 7 9  3 
240 Dharani 27 7065 40 1 10 4 9 180 15 10 205 FTNVD 1  2.75 NO NO NO NO 7 9  3 
241 Nithya 25 7089 40+1 1 10 4 10 360 30 10 400 FTNVD 1  3.2 YES NO NO NO 6 9  3 
242 Vembu 29 7100 38+6 1 10 4 7 210 20 10 240 FTNVD 1  2.6 NO NO NO NO 7 9  3 
243 Sangeetha 21 7136 38+2 1 10 4 9 380 45 20 445 FTNVD 2  3 NO NO NO NO 8 9  3 
244 Vali 18 7145 40+6 1 10 4 8 380 28 10 418 OUTLET 2 FD 2.75 NO NO NO NO 7 9  5 
245 Arokyaselvi 20 7170 39+5 2 10  10 260 22 10 292 FTNVD   2.25 NO NO NO NO 7 9  3 
246 Krishnapriya 21 7185 38+2 2 10  10 400 38 18 456 FTNVD   3 NO NO NO NO 6 9  3 
247 Sudha 24 7205 40 1 10 4 10 420 40 10 470 FTNVD 2  2.8 NO NO NO NO 6 9  3 
248 Maheshwari 21 7215 38+5 1 9 4 8 320 46 8 374 FTNVD 2  2.9 NO NO NO NO 7 9 VT 5 
249 Subaselvi 18 7232 37+2 2 10  9 240 30 10 280 FTNVD   3.25 NO NO NO NO 7 9  3 
250 Rajeshwari 19 7240 38+1 1 10 3 10 290 26 5 321 FTNVD 1  2.9 NO NO NO NO 8 9  3 
251 Mehraj Begum 24 7265 40+2 1 10 9 9 280 20 10 310 FTNVD 1  2.8 YES NO NO NO 7 9  3 
150 Sivagami 25 5450 37+4 2 9  10 290 15 10 315 FTNVD   2.6 YES NO NO NO 7 9  3 
151 Sundari 22 5479 40+3 2 10  10 200 23 10 233 FTNVD   2.5 NO NO NO NO 7 9  3 
152 Kavitha 22 5498 39+6 1 9 6 9 190 20 10 220 FTNVD 1  2.75 NO NO NO NO 6 9  8 
153 Dhanalakshmi 22 5601 40+5 2 9  9 220 10 5 235 FTNVD   2.8 NO NO NO NO 7 7 VT 5 
154 Revathy 23 5638 39+8 1 9 7 8 240 23 7 270 FTNVD 1  2.6 NO NO NO NO 8 8  3 
155 Shyamaladevi 20 5646 39+2 1 9 8 10 200 20 10 230 FTNVD 1  2.9 YES YES NO NO 6 8  3 
156 Kolanji 23 5677 37+2 2 9  10 290 35 7 332 FTNVD   3.2 NO NO NO NO 7 7  3 
157 Sudha 22 5681 38+5 2 9  10 240 35 5 280 FTNVD   3.3 NO NO NO NO 7 8  3 
158 Elavarasi 21 5690 39+1 1 10 8 9 280 25 10 315 LSCS 2 FD 2.5 NO NO NO NO 8 9  8 
159 Amutha 25 5700 37 2 10  9 270 30 10 310 FTNVD   2.6 NO NO NO NO 7 8  3 
160 Jothy 23 5731 37+6 2 9  10 340 20 10 370 FTNVD   2.9 NO NO NO NO 7 7  3 
161 Sivagamasundari 22 5746 39+2 2 10  9 310 23 7 340 FTNVD   2.76 NO NO NO NO 7 7  3 
162 Shanthi 21 5755 39+2 1 9 9 9 280 27 10 317 FTNVD 2  2.51 NO NO NO NO 8 9  3 
163 Lavanya 19 5782 39+1 2 10  10 140 20 10 170 FTNVD   2.76 NO NO NO NO 6 7  3 
164 Bhuvaneshwari 25 5797 38+6 1 8 9 10     LSCS 1 FD 3 NO NO NO NO 8 9  8 
165 Devi 20 5824 37+4 2 10  9 400 50 10 460 FTNVD   2.7 NO NO NO NO 7 7  3 
166 Sathiya 22 5845 39+4 2 10  10 260 20 10 290 FTNVD   2.9 NO NO NO NO 7 7  3 
167 Hepziba 23 5872 37+5 1 8 7 8 250 18 7 275 FTNVD 1  2.7 NO NO NO NO 8 9  3 
168 Shylaja 19 5888 39+1 2 10  10 320 28 10 358 FTNVD   2.8 NO NO NO NO 7 7  3 
169 Shakeela 24 5897 39+6 1 10 3 8 180 10 4 194 FTNVD 1  2.9 NO NO NO NO 8 9  3 
170 Nameetha 27 5899 40+1 2 10  10 270 22 8 300 FTNVD   3.1 NO NO NO NO 7 7  3 
171 Maheshwari 27 5914 37+2 2 10  9 190 23 10 223 FTNVD   2.7 NO NO NO NO 7 7 VT 5 
172 Praveena banu 22 5934 39+1 1 9 3 7 300 29 14 343 FTNVD 1  2.9 NO NO NO NO 8 9  3 
173 Radhiga 21 5941 37+1 2 9  9 230 22 6 258 FTNVD   2.54 NO NO NO NO 7 7  3 
174 Pushpavalli 22 5973 39+1 1 10 4 10 250 15 5 270 FTNVD 1  2.9 NO NO NO NO 6 9 VT 5 
175 Jansi rani 25 5955 38+1 1 8 4 10 330 31 7 368 FTNVD 2  3.3 NO NO NO NO 8 9  3 
176 kalaiselvi 21 6124 40 1 10 9 9 230 23 5 258 FTNVD 1  2.9 NO NO NO NO 8 8  3 
177 rajalakshmi 27 6170 40 2 10  9 280 25 10 315 FTNVD   3.1 NO NO NO NO 6 8  3 
178 selvarani 25 6173 39 1 8 7 10 250 18 7 275 FTNVD 1  2.9 NO NO NO NO 8 9  3 
179 Jansi rani 23 6174 40 1 10 8 8 280 25 10 315 FTNVD 2  3.1 NO NO NO NO 8 7  3 
180 Vijayalakshmi 24 6090 41 2 9  9 190 20 8 218 FTNVD   2.8 NO NO NO NO 6 8  3 
181 vagitha 25 6900 40 2 9  9 220 10 5 235 FTNVD   2.9 NO NO NO NO 7 8 VT 5 
182 sivagangai 25 6097 38 1 9 7 10 240 23 7 270 FTNVD 1  3 NO NO NO NO 8 8  3 
183 sasikala 27 6098 39 1 9 8 7 200 20 10 230 OUTLET 1 ME 3.8 NO NO NO NO 7 8  5 
184 gangai 27 6091 40 2 9  9 302 30 5 337 FTNVD   2.2 NO NO NO NO 6 7  3 
185 devikarasi 20 6112 40 2 9  10 288 45 7 340 FTNVD   2.8 NO NO NO NO 7 8  3 
186 jayalakshmi 28 6132 37 2 9  10 412 25 6 443 FTNVD   2.5 NO NO NO NO 7 8  3 
187 jansirani 26 6134 38 1 10 7 9 550 20 7 577 FTNVD 2  2.6 NO NO NO NO 8 8  3 
188 manjuladevi 25 6135 38.5 2 9  9 306 18 10 328 FTNVD   3 NO NO NO NO 7 8 VT 5 
189 valamathy 23 6161 40 2 9  10 320 65 10 395 FTNVD   2.45 YES NO NO NO 7 8  3 
190 sumathy 22 6164 39 1 10 7 9 300 18 12 330 FTNVD 2  2.6 NO NO NO NO 8 7  3 
191 deepa 23 6153 41 2 9  9 320 25 5 350 FTNVD   2.76 NO NO NO NO 7 8  3 
192 deepthi 22 6157 40 1 8 8 10 200 15 5 220 FTNVD 1  3.1 NO NO NO NO 8 7  3 
193 mahalakshmi 23 6132 39 2 10  9 320 45 10 375 FTNVD   3.5 NO NO NO NO 7 7  3 
194 saritha 22 6137 38 1 10 7 10 200 18 10 228 FTNVD 1  2.8 YES YES NO NO 6 7  3 
195 rubini 21 6134 39 2 10  9 220 20 10 250 FTNVD   2.61 NO NO NO NO 7 7  3 
196 madhavi 28 6144 40 2 10  10 190 10 5 205 FTNVD   2.3 NO NO NO NO 7 8  3 
197 anandajothy 24 6145 38 1 9 9 8 180 15 5 200 FTNVD 1  2.54 NO NO NO NO 8 7 VT 5 
198 rajalakshmi 25 6147 38 2 10  10 260 10 5 275 FTNVD   2.7 NO NO NO NO 7 9  3 
199 arivuselvi 27 6149 39 2 10  10     LSCS  FD 2.9 NO NO NO NO 6 9  8 
200 uma 28 6166 40 2 10  10     LSCS  FD 2.5 NO NO NO NO 6 9  8 
99 Rajeshwari 19 14515 38 1 10 9 7 230 22 6 258 FTNVD 1  3 NO NO NO NO 7 8  3 
100 Nadhiya 19 14528 39+4 2 10  9 250 15 5 270 FTNVD   3.12 NO NO NO NO 7 8  3 
101 Kalpana 25 4090 37+6 2 9  10 340 20 10 370 FTNVD   2.75 NO NO NO NO 6 8  3 
102 Saroja 24 4198 38 2 10  10 320 20 7 347 FTNVD   2.5 NO NO NO NO 7 8  8 
103 Latha 21 4367 38+3 2 10  9 360 30 10 400 FTNVD   3.2 NO NO NO NO 7 8  3 
104 Thangamani 24 4587 38+2 1 10 9 9 280 55 15 350 FTNVD 2  3.1 NO NO NO NO 8 7  3 
105 Malathy 25 4198 39+1 2 10  9 200 20 10 230 FTNVD   2.8 NO NO NO NO 7 8  3 
106 Umamaheshwari 20 4087 39+5 1 9 6 9 320 35 15 370 FTNVD 2  2.56 NO NO NO NO 8 7  3 
107 Vijayalakshmi 25 4659 40+5 2 10  10 280 23 7 310 FTNVD   3 NO NO NO NO 6 8  3 
108 Indira 25 4065 39+3 1 10 5 10 240 24 10 274 FTNVD 1  2.9 NO NO NO NO 8 9  3 
109 Seethalakshmi 22 4213 39+1 2 9  10 300 23 10 333 FTNVD   2.5 NO NO NO NO 7 8 VT 5 
110 Poovazhagi 23 4270 39+2 1 8 7 8 210 15 7 232 FTNVD 1  2.56 NO NO NO NO 8 7  3 
111 Vembu 28 4300 38+1 2 9  10 340 35 10 385 FTNVD   2.6 NO NO NO NO 6 7  3 
112 Sheela 30 4367 38+5 1 10 8 9 280 25 5 310 FTNVD 2  2.4 NO NO NO NO 7 8  3 
113 Senthamarai 32 4385 40 1 9 7 10 300 21 7 328 FTNVD 2  2.43 NO NO NO NO 8 9  3 
114 Vimala 30 4431 37+6 2 10  9 200 15 5 220 FTNVD   3.4 NO NO NO NO 7 7 VT 5 
115 Malliga 21 4475 38+5 2 9  9 190 20 8 218 OUTLET  ME 3 YES NO NO NO 6 8  5 
116 Sudha 20 4490 38+1 2 10  10 280 38 10 328 FTNVD   2.65 NO NO NO NO 7 8  3 
117 Amsavalli 22 4532 39+3 2 10  9 300 40 10 350 FTNVD   2.8 NO NO NO NO 7 7  3 
118 Pallavi 24 4594 39+1 1 10 9 7 180 20 5 205 FTNVD 1  2.45 NO NO NO NO 8 8 VT 5 
119 Karpagam 26 4612 39+1 1 9 8 9 210 25 10 245 FTNVD 1  2.6 NO NO NO NO 8 8  3 
120 Saridha 28 4637 38+5 2 8  9     LSCS  FD 2.76 NO NO NO NO 7 7  8 
121 Umadevi 30 4657 38+1 1 10 8 8 250 23 10 283 FTNVD 1  3.1 NO NO NO NO 8 9  3 
122 Revathy 19 4689 38+5 2 10  10 310 20 10 340 FTNVD   3.5 NO NO NO NO 7 8 VT 5 
123 Visalatchi 18 4609 38+1 1 9 9 10 250 20 7 277 FTNVD 1  2.8 NO NO NO NO 7 8  3 
124 Vembarasi 20 4700 39 1 9 8 9 200 15 5 220 OUTLET 1 ME 2.61 YES NO NO NO 8 8  5 
125 Marystella 23 4714 38+2 2 10  10 360 30 10 400 OUTLET  ME 2.3 NO NO NO NO 7 8 VT 5 
126 Indira 20 4724 39+2 2 10  9 290 30 10 330 FTNVD   2.54 NO NO NO NO 7 7  3 
127 Punitha 25 4745 39+5 2 10  10 320 20 10 350 FTNVD   2.7 NO NO NO NO 7 8 VT 5 
128 Chandra 25 4768 40+1 2 10  9 240 28 12 280 FTNVD   2.9 NO NO NO NO 7 9  3 
129 Elavarasi 25 4790 39+1 1 10 7 8 200 10 10 220 FTNVD 1  2.5 NO NO NO NO 7 8 VT 5 
130 Shanmuga priya 21 4801 38+3 1 7 6 10     LSCS 1 FD 3 YES NO NO NO 7 9  8 
131 Kavitha 23 4829 39+2 2 10  10 300 25 10 335 FTNVD   3 NO NO NO NO 7 9 VT 5 
132 Bhuvaneshwari 18 4834 38+1 2 10  9 180 25 10 215 FTNVD   3.2 NO NO NO NO 8 9  3 
133 Abirami 25 4855 38+6 1 8 6 8 360 45 15 420 OUTLET 2 ME 3.8 NO NO NO NO 8 8  5 
134 Devi 22 4871 39+1 2 10  10 280 30 10 320 FTNVD   3.5 NO NO NO NO 6 9  3 
135 Sangeetha 21 4899 38+2 1 8 7 9 320 30 10 360 FTNVD 2  2.74 NO NO NO NO 8 8  3 
136 Maheshwari 23 4900 39+1 1 9 9 7 240 31 13 284 FTNVD 1  2.6 NO NO NO NO 8 9  3 
137 Elamathy 22 4931 38+6 1 9 8 10 220 30 15 265 FTNVD 1  2.4 NO NO NO NO 8 9  3 
138 Ranjani 25 4942 39+2 1 10 9 9 270 24 8 302 FTNVD 1  2.75 NO NO NO NO 8 9  3 
139 Tamilarasi 25 4958 38+6 2 10  10 310 30 10 350 FTNVD   3.1 YES NO NO NO 6 9  3 
140 Nishanthi 20 4970 39+3 1 8 8 9     LSCS 1 FD 2.8 NO NO NO NO 8 9  8 
141 Mala 23 4985 39+1 2 10  10 320 20 5 345 FTNVD   2.5 YES NO NO NO 6 9  3 
142 Mahalakshmi 22 4999 39+6 2 9  9 210 25 10 245 FTNVD   2.4 NO NO NO NO 6 9  3 
143 Chandrakala 21 5000 39+2 1 8 9 8     LSCS 1 FD 2.76 NO NO NO NO 8 9  8 
144 Devi 18 5102 37+1 1 10 7 10 250 23 10 283 FTNVD 1  2.8 NO NO NO NO 8 8  3 
145 Kalaivani 24 5325 40 2 10  10 310 20 10 340 FTNVD   2.9 NO NO NO NO 6 9  3 
146 Jothy 25 5375 39+5 2 9  9 380 20 7 407 OUTLET  FD 3.5 NO NO NO NO 7 9  5 
147 Manimegalai 22 5413 38+3 1 9 6 10 240 30 10 280 FTNVD 1  3 NO NO NO NO 7 8  3 
148 Aboorvam 25 5454 37+2 2 10  9 290 23 17 230 FTNVD   3.4 NO NO NO NO 6 9 VT 3 
149 Senbagam 23 5467 39+3 1 8 6 8 150 10 5 165 FTNVD 1  3.2 NO NO NO NO 8 9  3 
48 Chandhini 25 14257 39+1 2 10  9 200 20 10 230 OUTLET  ME 2.4 NO NO NO NO 7 8 VT 5 
49 Kalaivani 22 14125 38+4 1 10 6 10 180 25 10 215 FTNVD 1  3.2 NO NO NO NO 7 9  3 
50 Asha 19 14212 38+4 2 10  10 360 26 14 400 FTNVD   3.2 NO NO NO NO 7 8  3 
51 Tamizhselvi 21 14190 40 1 7 7 9     LSCS 1 FD 3.2 YES NO NO NO 7 9  8 
52 Hemalatha 22 14254 38+6 2 8  9     LSCS  FD 2.2 NO NO NO NO 7 8  8 
53 Nithya 31 14272 38+4 2 9  9 300 28 12 340 FTNVD   3.45 NO NO NO NO 7 8 VT 5 
54 Sasikala 26 14302 39+4 2 10  10 360 20 10 390 FTNVD   2.95 YES NO NO NO 7 9  3 
55 Krishnaveni 21 14311 39+4 1 10 8 9 280 10 5 295 FTNVD 1  2.75 NO NO NO NO 7 8  3 
56 Amudha 31 14271 38+6 1 10 8 7 340 30 10 380 FTNVD 2  3.2 NO NO NO NO 7 9  3 
57 Sammu 20 14313 37+1 2 8  9 220 10 10 240 FTNVD   2.75 NO NO NO NO 7 9  3 
58 Yuvaranjini 37 14323 39+2 2 8  10 270 30 15 315 FTNVD   2.25 NO NO NO NO 8 9  3 
59 Poornima 32 14319 40+5 2 8  9     LSCS  FD 2.9 NO NO NO NO 7 9  8 
60 Santhakumari 34 14229 38+1 1 7 7 10     LSCS 1 FD 2.6 NO NO NO NO 7 9  8 
61 Tejashree 36 14233 40+1 2 10  10 270 25 5 300 FTNVD   3.5 NO NO NO NO 8 9  3 
62 Gayathri 23 14304 37+3 2 8  9     LSCS  FD 3.5 YES NO NO NO 7 9  8 
63 Jeevarathinam 26 14361 39+5 2 8  10     LSCS  FD 2.25 NO NO NO NO 6 9  8 
64 Jameela 31 14315 39+4 2 10  10 260 24 6 290 FTNVD   2.75 NO NO NO NO 7 9  3 
65 Rajeshwari 36 14326 38+6 1 6 8 8     LSCS 1 FD 3.3 NO NO NO NO 7 8  8 
66 Kalaiselvi 33 14360 39+1 1 10 2 10 240 25 10 275 FTNVD 1  3 NO NO NO NO 7 8  3 
67 Vasanthi 19 14337 38+2 2 10  9 310 17 5 332 FTNVD   2.8 YES NO NO NO 7 9  3 
68 Ruckmani 22 14380 37+2 2 8  9     LSCS  FD 2.7 NO NO NO NO 6 9  8 
69 Umamaheshwari 18 14332 37+6 1 9 3 7 200 25 5 230 FTNVD 1  2.6 NO NO NO NO 7 8  3 
70 Priyanka 20 14367 39+2 2 10  9 320 60 10 390 FTNVD   3.5 NO NO NO NO 7 9  3 
71 Bakyalakshmi 18 14345 37+2 2 10  9 400 25 5 430 FTNVD   3.7 NO NO NO NO 7 9  3 
72 Kavitha 19 14382 38+4 1 9 4 9 240 12 8 260 FTNVD 1  3.45 NO NO NO NO 8 9  3 
73 Nandhini 22 14383 38+4 2 10  10 280 30 7 317 FTNVD   3 NO NO NO NO 6 9 VT 5 
74 Priya 19 14312 38+4 1 9 3 9 220 25 10 255 FTNVD 1  2.2 NO NO NO NO 8 8 VT 5 
75 Lalitha 22 14167 38+6 2 8  9 280 15 10 305 FTNVD   2.75 NO NO NO NO 6 7  3 
76 Manjula 23 14376 40+2 1 9 3 8 290 13 5 308 FTNVD 1  2.8 NO NO NO NO 7 8  3 
77 Jeyanthi 19 14393 37+2 2 8  10 300 18 12 330 FTNVD   2.75 NO NO NO NO 8 8  3 
78 Shanthi 36 14410 39 1 10 4 10 200 10 5 215 FTNVD 1  3.2 NO NO NO NO 8 7  3 
79 Swathi 24 14338 38+2 1 10 10 8 180 10 4 194 FTNVD 1  3.5 YES NO NO NO 7 9  3 
80 Jayanthi 20 14082 39+4 2 10  10 320 25 5 350 FTNVD   2.3 NO NO NO NO 7 8  3 
81 Yuvarani 23 14395 37+2 1 10 9 9 280 30 10 320 FTNVD 2  2.5 NO NO NO NO 7 8 VT 5 
82 Tamil arasi 23 14388 40 2 10  9 290 18 5 313 FTNVD   2.8 NO NO NO NO 7 8  3 
83 Sayeed suleka 18 14450 39+1 2 10  9 280 15 5 300 FTNVD   2.7 NO NO NO NO 7 8  3 
84 Banu 23 14392 38+2 1 9 8 7 270 15 5 290 FTNVD 1  3.3 NO NO NO NO 7 8  3 
85 Sangeetha 20 14237 39+1 2 10  10 320 65 10 395 FTNVD   3.2 NO NO NO NO 6 7  3 
86 Nafisa 22 14122 37+5 2 8  9 300 18 12 330 FTNVD   2.6 YES NO NO NO 7 8  3 
87 Sasikala 21 14482 38+3 2 10  10 320 25 5 350 FTNVD   2.9 NO NO NO NO 6 7  3 
88 Gayathri 21 14172 39+6 1 10 3 10 200 15 5 220 OUTLET 1 FD 3.8 NO NO NO NO 8 8 VT 5 
89 Nirosha 22 14469 39 2 10  9 320 45 10 375 FTNVD   2.55 NO NO NO NO 6 8 VT 5 
90 Eshwari 30 14230 38+2 1 10 4 8 200 18 10 228 FTNVD 1  3.2 NO NO NO NO 7 8  3 
91 Ponni 20 14330 40+2 2 10  10 300 44 18 362 FTNVD   2.7 NO NO NO NO 7 8  3 
92 Yuganya 23 14504 40 2 9  10 280 15 5 300 FTNVD   3.1 NO NO NO NO 7 8  3 
93 Priya 22 14325 39+4 2 10  10 210 21 7 238 FTNVD   2.56 NO NO NO NO 8 8 VT 5 
94 Amalakrishnan 21 14487 39+3 1 9 7 9 300 18 6 324 FTNVD 2  2.8 NO NO NO NO 8 8  3 
95 Rani 25 14474 39+2 2 9  10 230 32 10 272 FTNVD   3.5 NO NO NO NO 6 7  3 
96 Dhanalakshmi 20 14484 39+2 2 10  9 200 20 5 225 FTNVD   2.55 YES NO NO NO 7 8  3 
97 Tamil selvi 20 14500 40+2 1 9 9 10 190 23 10 223 OUTLET 1 ME 3.75 NO NO NO NO 7 9 VT 5 
98 Kanaga 23 14507 39+1 2 9  10 300 29 14 343 FTNVD   2.98 NO NO NO NO 7 8  3 
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1 Nagavalli 21 14093 39+4 1 9 4 10 220 30 5 255 FTNVD 1  2.9 NO NO NO NO 6 8  3 
2 Divya 20 14101 39+6 2 8  9     LSCS  FD 2.7 NO NO NO NO 7 9  8 
3 Thilagavathy 20 14112 37+2 1 10 4 7 300 49 7 356 FTNVD 2  2.1 NO NO NO NO 7 8  3 
4 Jayasudha 21 14079 38+1 2 10  9 420 40 10 470 FTNVD   3 NO NO NO NO 7 9  3 
5 Jeevarathinam 23 14079 39+2 1 9 8 10 180 10 10 200 FTNVD 1  2.1 NO NO NO NO 7 8  3 
6 Nalini 24 14103 37+3 2 10  10 360 31 17 408 FTNVD   2.5 NO NO NO NO 7 8  3 
7 Devi 25 14062 38+4 2 9  9 280 24 12 316 FTNVD   2.6 NO NO NO NO 7 8  3 
8 Bakyalakshmi 20 13904 40 1 9 4 8 240 20 5 265 FTNVD 1  3 NO NO NO NO 7 8  3 
9 shamsath 20 14065 39+3 2 10  9 375 65 10 450 FTNVD   2.5 NO NO NO NO 7 7  3 
10 Thulasi 20 14009 39+4 1 9 4 8 180 15 10 205 FTNVD 1  2.75 NO NO NO NO 7 8  3 
11 Parimala 19 14087 38+5 2 10  10 360 30 10 400 FTNVD   3.2 YES NO NO NO 6 7  3 
12 Sudha 22 14110 39+2 1 9 4 10 210 20 10 240 FTNVD 1  2.6 NO NO NO NO 7 8  3 
13 Pushpalatha 20 14156 39+2 1 8 7 9 380 45 20 445 FTNVD 2  3 NO NO NO NO 8 8  3 
14 Durgadevi 22 14155 38+3 2 10  9 380 28 10 418 OUTLET  FD 2.75 NO NO NO NO 7 7 VT 5 
15 Thirushanthi 21 14129 38+4 1 9 7 7 260 22 10 292 FTNVD 1  2.25 NO NO NO NO 7 8  3 
16 Nirosha 24 14123 38+5 2 10  10 400 38 18 456 FTNVD   3 NO NO NO NO 6 7  3 
17 Seetha 20 14137 37+5 1 6 7 7 420 40 10 470 FTNVD 2  2.4 NO NO NO NO 6 7  3 
18 Bhavani 25 14135 39+2 1 9 9 10 320 46 8 374 FTNVD 2  2.9 NO NO NO NO 7 8 VT 5 
19 Yamini 19 14129 37+3 2 10  10 240 30 10 280 FTNVD   3.25 NO NO NO NO 7 7  3 
20 Riyana 20 14109 39 1 10 4 8 290 26 5 321 FTNVD 1  2.9 NO NO NO NO 8 7 VT 5 
21 Rajeshwari 25 14176 39+2 2 10  10 280 20 10 310 FTNVD   2.8 YES NO NO NO 7 7  3 
22 Saranya 21 14116 39+2 1 9 4 8 320 65 10 395 FTNVD 2  3 NO NO NO NO 8 7  3 
23 Manjula 26 14163 39+5 1 8 4 7 240 19 7 266 FTNVD 1  2.75 NO NO NO NO 7 7  3 
24 Suma banu 21 13810 39+2 1 6 5 9     LSCS 1 FD 2.4 NO NO NO NO 7 7  8 
25 Rajeshwari 22 14178 39+4 1 10 5 7 200 26 8 234 FTNVD 1  2.65 NO NO NO NO 6 7 VT 5 
26 Radha 21 14099 39+2 1 10 7 10 220 20 10 250 FTNVD 1  2.6 NO NO NO NO 7 8  3 
27 Altina 26 14186 39+5 2 10  9 270 21 17 308 OUTLET  FD 2.9 NO NO NO NO 7 7  5 
28 Anandhi 29 14111 38+2 2 10  10 335 48 10 393 FTNVD   2.5 NO NO NO NO 7 7  3 
29 Naveena 29 14132 38+6 2 10  10 300 24 6 330 FTNVD   3 NO NO NO NO 7 7 VT 5 
30 Yamini 27 13925 39+5 1 9 4 9 280 20 10 310 FTNVD 1  2.7 NO NO NO NO 7 8  3 
31 Lavanya 26 14170 39+6 1 9 4 8 200 33 7 240 OUTLET 1 ME 3.5 NO NO NO NO 7 8 VT 5 
32 Nagma begum 30 13923 38+1 1 9 4 10 260 15 10 285 FTNVD 1  2.8 NO NO NO NO 7 8  3 
33 Tamizhselvi 19 14220 39+5 1 9 4 7 230 20 10 260 FTNVD 1  2.4 NO NO NO NO 7 8  3 
34 Divya 34 14194 38+5 2 9  9 260 15 5 280 FTNVD   2.3 NO NO NO NO 6 7  3 
35 Sreemathi 22 14221 37+3 1 9 6 8 240 35 5 280 FTNVD 1  2.75 NO NO NO NO 7 8  3 
36 Mahadevi 34 14158 39+2 2 10  9 320 30 10 360 FTNVD   3.3 NO NO NO NO 7 7  3 
37 Surya 33 13871 39+1 2 10  9 240 15 5 260 FTNVD   3.2 NO NO NO NO 7 8  3 
38 Ramya 32 13638 38+1 1 9 7 10 300 40 20 360 FTNVD 2  2.1 YES NO NO NO 7 9  3 
39 Theresa 28 14223 38+3 2 10  9 260 25 10 295 FTNVD   2.5 NO NO NO NO 7 8  3 
40 Latha 19 14222 38+6 1 10 8 9 310 25 10 345 FTNVD 2  2.65 NO NO NO NO 6 7  3 
41 Sathya 22 14235 39+2 2 10  10 300 55 10 365 FTNVD   2.4 NO NO NO NO 7 8  3 
42 Laila 19 14229 38+6 2 9  10     LSCS  FD 2.6 NO NO NO YES 7 8  8 
43 Chandralekha 23 13103 39+2 1 10 10 9 220 17 13 250 FTNVD 1  2.75 NO NO NO NO 7 7  3 
44 Rihana 33 14234 38+3 1 9 7 10 360 38 12 410 FTNVD 2  2.55 NO NO NO NO 7 8  3 
45 Mahalakshmi 20 14248 37+6 2 10  10 240 28 12 280 FTNVD   2.4 NO NO NO NO 7 8  3 
46 Parameshwari 31 14253 38+5 1 10 4 7 300 19 13 332 FTNVD 2  2.7 NO NO NO NO 7 8  3 
47 Anuradha 32 14243 38+3 1 9 4 8 320 30 10 360 FTNVD 2  3.2 NO NO NO NO 7 8  3 
No. CODE NAME OF VARIABLE
1 S.no Serial number
2 NAME Names of cases
3 AGE Ages in years
4 GA Gestational Age
5 GROUP Group 1-Study    Group 2-control
6 DOPS1 Degree Of Pain Stage 1
7 DOPS1AF Degree Of Pain Stage 1 After drug in study group
8 DOPS2 Degree Of Pain Stage 2
9 DOLST1 Duration Of Labour Stage 1
10 DOLST2 Duration Of Labour Stage 2
11 DOLST3 Duration Of Labour Stage 3
12 DOLTOT Duration Of Labour Total
13 MOD Mode of  delivery
14 IND Indications for LSCS and forceps
15 BWT Birth weight
16 NA/VOM Nausea,Vomiting
17 DROW Drowsiness
18 PALPI Palpitation
19 RD Respiratory Distress
20 APG1 Apgar 1 minute
21 APG5 Apgar 5 minute
22 MC Maternal complication
23 HS Hospital Stay
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